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Abstract 
Bacterial resistance to standard antibiotic therapies is a critical health problem 
worldwide. Antimicrobial-resistant infections that are essentially untreatable have 
begun to occur as epidemics around the globe. In this thesis, I have used the 
techniques of coordination chemistry, molecular biology, and protein X-ray 
crystallography to study metal binding to ferric ion binding protein (FBP), a highly-
conserved 34 kDa periplasmic iron transporter, a candidate as target for novel 
metalloantibiotic design. 
FBP from the human pathogen Neisseria gonorrhoeae was overexpressed with 
recombinant DNA technology. Metal-free FBP and reloaded Fe-NTA-FBP and Fe3-
FBP were fully characterised in solution and were crystallised. Structural 
comparisons among the crystal structure of apo-FBP (1.9 A resolution), Fe-NTA-
FBP (1.8 A resolution) and Fe3-FBP (1.8 A resolution) show that the characteristic 
dityrosyl motif of FBP can assemble/bind metal clusters in the open metal binding 
cleft of the protein, although closure of the hinged metal-binding cleft and the 
presence of the synergistic anion (phosphate) are usually considered obligatory for 
strong metal binding by FBP. The role of dityrosyl motif in metal binding was 
confirmed by studies on two mutant FBPs (E57H FBP and Y195H Y196H FBP). 
Hf(IV) was loaded on to apo-FBP under physiological conditions. Hf-FBP was 
characterised in solution and was crystallised. As observed for reload Fe-FBP, the 
crystal structure of Hf-bound form of FBP (1.7 A resolution) shows that the 
phosphate ion in the crystal structure of apo-FBP can be displaced by mononuclear 
[Hf(NTA)2]2 , yielding a range of oxo Hf(IV) clusters containing from 3 to 5 metal 
ions bound to FBP strongly in the open metal-binding cleft of FBP. 
The binding of vanadate to apo-FBP was studied by 51V NMR, and the data suggest 
that vanadate can bind similarity to phosphate and also as a vanadium cluster. 
Crystals of V-FBP were obtained which diffract to 2.0 A. 
'Ii 
The work in this thesis suggests a novel metal acquisitive mechanism, which reveals 
the possibility that bacterial metal uptake is mediated by novel FBP intermediates 
including cluster adducts. 
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Chapter 1 Introduction 
Chapter 1 Introduction 
1.1 Metal Ions in Biological Systems 
Metal ions play key roles in biological systems. It has been estimated that over 50% 
of all proteins will turn out to be metalloproteins [1]. Metal-ion-containing molecules 
generally serve important functions as electron carriers, metal storage sites, 02 
binding and storage sites and in signal transduction [2]. 
There is a tradition to use inorganic compounds for therapy. Platinum anticancer, 
gold antiarthritic and bismuth anticancer drugs have been developed. Metal 
complexes are routinely used as contrast agents for MRI and other imaging 
techniques [3]. A focal point of bioinorganic research is the chemistry of metal ions 
and their role for life [4]. 
The structures of metal complexes are important because research on mechanisms is 
based on structural research. To understand biological processes at the molecular 
level, with the help of modern technology, complete protein sequences and X-ray 
structures have been achieved for large complex molecules with important biological 
functions. 
It is particularly important to understand the nature of the interactions of metallo-
drugs with cell membranes, proteins, enzymes and DNA. The increasing knowledge 
of the role of metals in genetic regulation and the nature of metal sensor, transport 
and chaperone proteins will eventually have a major impact on drug design [2]. 
1.2 Bacterial Iron Uptake Systems 
1.2.1 Iron Availability and Storage of Iron in Cells 
Iron is essential for the growth of most bacteria due to its diverse roles in the 
biochemistry of the cell. In aerobic environments, the solubility of iron is very low at 
physiological pH (108  M). Hence, the bio-availability of iron is poor although iron 
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is the most abundant transition metal on Earth. Insoluble ferric hydroxide complexes 
form in solution, severely limiting the amount of free iron [5]. The majority of iron in 
a mammalian host is intracellular being present as haern compounds and iron-sulphur 
clusters in various proteins, and in the storage molecule ferritin. Extracellular iron is 
complexed to transferrin and lactoferrin, and sometimes to citrate [6, 7]. In order for 
iron to be used by a bacterium, specialised uptake mechanisms are necessary to 
extract iron from the environment or the host. Once inside the bacterial cell, the 
major role of iron is its involvement in enzymatic redox reactions. However, iron can 
also play a structural role in proteins and change the reactivity of active site residues 
[8]. 
1.2.2 Transport of Iron Across the Outer Membrane 
Several types of iron uptake systems exist in bacteria to obtain iron from the 
environment or an animal host, by directly binding iron or iron-binding proteins or 
by utilizing iron chelators [9, 10, 11], which are low molecular compounds called 
siderophores, and have a high affinity for iron. Most pathogenic bacteria can procure 
iron directly from the host's iron-binding proteins, transferrin (Tf) and lactoferrin(Lf) 
[12, 131, or indirectly from haem from hemoglobin (Hb) [14]. Under anaerobic 
conditions, Fe(II) is present. It is sufficiently soluble that it can be taken up by 
anaerobic bacteria without the help of iron chelators. Similarly, acid-tolerant bacteria 
might find enough Fe(III), which has a solubility of 108  M at pH 3, to supply their 
iron needs. 
In Gram-negative bacteria, access to the iron-binding proteins is prevented by the 
outer membrane, which forms a permeability barrier for substrates of more than 600 
Da, so transport of iron in Gram-negative bacteria involves a specific outer 
membrane receptor whereas in Gram-positive organisms, which lack an outer 
membrane, the receptor protein is anchored by a covalently linked lipid [15]. A 
periplasmic transport protein and several inner membrane associated proteins 
complete the transport of iron into the cell [9, 10]. This arrangement of proteins from 
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systems, termed ABC transporters (for ATP binding cassette-type transport), which 












Figure 1.1 Fe(III) uptake system of Gram-negative bacteria. Fe(III) is delivered by 
lactoferrin or transferrin, haem or haem bound to hemoglobin or hemopexin of the 
host organisms, or siderophores. The receptor proteins (shown in blue) transport 
iron/iron ligand across the outer membrane: TbpA-TbpB (shown in darker blue) 
transports Fe(III); HasR (shown in mid-blue) transports haem, and FhuA (shown in 
lighter blue) transports ferrichrome. Active transport across the outer membrane is 
energized by the proton gradient across the cytoplasmic membrane. Presumably, 
conformational energy is transferred from the cytoplasmic membrane to the outer 
membrane by a protein complex consisting of the TonB, ExbB and ExbD proteins 
(shown in yellow). In the periplasm, Fe(III), haem or Fe(III) siderophores bind to 
binding proteins. The binding proteins deliver the iron compounds to transport 
proteins in the cytoplasmic membrane (shown in green); these transport proteins - 
for example, FhuB, translocates the iron compounds into the cytoplasm at the 
expense of ATP. The respective ATPases are associated with the inside of the 
C] 
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cytoplasmic membrane. Fe 2+  presumably diffuses across the outer membrane and is 
actively transported across the cytoplasmic membrane by proteins (shown in red) [9]. 
Iron uptake does not necessarily begin with transport of iron by the requisite outer 
membrane receptors. Bacteria synthesise and secrete siderophores and hemophores 
in order to chelate iron or haem, and deliver them to the outer membrane receptors. 
The chemical structures of many different siderophores are well known [19]. Also, 
the structures of some outer membrane receptor proteins have been reported [22, 23, 
24, 25]. 
A number of factors contribute to the existence of specific outer membrane receptors 
for ion uptake. Numerous receptors, between 75 and 85 kDa in size, bind their 
ligands with a very high affinity and with the specificity to transport compounds 
against a concentration gradient using energy from the inner membrane associated 
TonB-ExbB-ExbD complex [20, 21]. There is no source of energy in the form of an 
electrochemical gradient in the outer membrane nor are there any high energy 
compounds, such as ATP, in the periplasm. The initial transport across the outer 
membrane utilizes the electrochemical potential of the inner membrane. Its energy is 
coupled to the outer membrane by the TonB-ExbB-ExbD complex. Transferrin, 
Lactoferrin and haem protein receptors function to recruit these proteins to the cell 
surface and extract their iron. Although most substrates can diffuse through open 
porin channels in the outer membrane, haem complexes and ferric siderophores are 
too large to pass into the periplasm through this route, so outer membrane receptors 
are required to facilitate their transport. Since the concentration of ferric siderophores 
and haem in the external medium is low, high affinity receptor proteins are utilized 
by the bacterium, thereby concentrating them at the cell surface and increasing their 
rate of transport. Competition with other microrganisms for the same siderophore 
also favours having a receptor with high affinity. Since the receptor is usually rather 
specific for a particular compound, the bacteria can avoid taking up compounds 
which have antimicrobial effects, such as siderophore mimetic antibiotics [8]. 
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1.2.2.1 Structure and Function of FepA, FhuA and FecA 
The crystal structures of three outer membrane receptors for siderophores, ferric 
enterobactin receptor FepA [22], ferrichrome receptor FhuA [23, 24] and ferric 
citrate receptor FecA [25] from E.coli have been determined. The structures reveal 
interesting features that are likely to be related to their function and mechanism of 
transport utilised by other membrane receptors involved in ligand uptake. All three 
proteins are composed of three distinct domains: a barrel domain, a plug domain and 
a NI-12-terminal extension. 
A B 
Figure 1.2 Comparison of the crystallographic structures of FecA, FhuA, and FepA 
in ribbon representation. (A) FecA, (B) FhuA, (C) FepA [26]. 
In all three structures, the monomeric transmembrane 13-barrels are composed of 22 
antiparallel strands. In vivo, these antiparallel strands transverse the outer membrane. 
Adjacent strands are connected by solvent-accessible extracellular loops containing 
two a-helices and three-13 strands; turns are oriented toward to the periplasm. The 
position and length of these connecting segments are different for each receptor. Two 
girdles of aromatic residues inscribe the membrane-embedded hydrophobic surface 
of the receptor [25]. 
The plug domain of FecA is located inside the barrel, comprising five helices, two 13-
strands, and a mixed four-stranded 13-sheet that is tilted by about 450  with respect to 
the membrane plane. FhuA and FepA present a similar fold [25]. 
Chapter 1 Introduction 
The N-terminal domain folds in from the periplasmic side, almost filling up the space 
inside the barrel and contributing sites for ligand binding. The usual N-terminal cork 
domain found in both FepA and FhuA has been implicated in both siderophore 
recognition and binding. The domain sits in the fl-barrel, anchored by more than 40 
hydrogen bonds and several salt bridges with the barrel strands, blocking the pore. 
The unique fold of the domain allows several loops to rise above the bilayer interface 
extending towards the extracellular loops of the barrel. The N-terminal domain is 
important for function and the highest degree of sequence homology between these 
active transport proteins is found in this region [22]. Although the N-terminal 
residues appear to block the pore, a narrow water-filled channel in the FhuA 
structure connects the binding site to the periplasm [23]. Several residues in a loop of 
the cork domain [27] and along the inner wall of the barrel [23] are highly conserved 
between FhuA proteins in other bacteria. The flexible domain of FecA termed the 
NH2-terminal extension was not visible in the electron density maps of the published 
crystal structure and could not be modelled [25]. The residues of this domain are 
entirely within the periplasm and transmit the liganded status of the receptor to FecR 
[28, 29]. 
The binding sites in three receptor proteins are different. In the structure of 
ferrichrome-bound FhuA, ferrichrome is found bound above the bilayer interface by 
interactions with residues from both the extracellular loops and the N-domain. The 
binding site of FhuA is predominantly formed by hydrophobic residues. The shape of 
the binding pocket, lined with aromatic residues, is highly complementary to the 
three dimensional conformation of ferrichrorne. Three residues from the N-domain as 
well as two residues from the barrel form hydrogen bonds to ferrichrome, 
contributing to tight binding [23, 24]. Four hydrogen bonds are formed with the 
hydroxamic acid portion of the ferric siderophore while two more bonds form with 
the peptide backbone [8]. Tentative identification of the binding site residues in 
FepA involved in ferrienterobactin binding is based on the characteristics of the 
siderophore. From the position of the putative iron sites in the crystal structure [22] 
and mutagenesis studies [30], residues important in the binding site include aromatic 
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and positively-charged residues from both the extracellular loops and the N-domain 
loops. In the same way, residues from receptors involved in binding other 
siderophores would possess chemical and structural characteristics complementary to 
the ligand. In addition, receptors for the same siderophore in different species could 
possibly be structurally related [8]. A single dinuclear ferric citrate molecule can 
bind within the external pocket of FecA [25]. Three loops of the plug domain extend 
above the plane of the upper leaflet of the outer membrane. In the liganded structure, 
three loops together with residues located on extracellular loops form hydrogen bonds 
and electrostatic interactions with dinuclear ferric citrate. 
Combined with the latest observations for this family of TonB-dependent receptors, a 
transport mechanism has been derived [25]. Stage 1: the siderophore is adsorbed 
from the medium with low affinity, primarily by aromatic residues found within the 
upper portion of the external pocket of the unliganded receptor. Stage 2: the 
siderophore is transferred to its high-affinity binding site, where primarily apices A, 
B, and C of the plug domain and numerous charged residues found within the 
extracellular loops and strands of the barrel form electrostatic contacts with the 
siderophore. These interactions cause translations of apices A, B, and C toward and 
away from the siderophore, as well as the concerted downward movement of other 
plug domain segments, leading to the unwinding and repositioning of the switch 
helix and the TonB-box. Stage 3: multiple extracellular loops of the receptor change 
their relative conformation and position. This bipartite gating mechanism closes the 
external pocket of the barrel, thereby favoring directed transport by disrupting the 
low-affinity binding site and shielding the high-affinity binding site from the solvent. 
However, the structural transitions observed in stages 2 and 3 may also be concerted. 
Stage 4: given the absence of an unobstructed channel of sufficient size to 
accommodate the passage of siderophores through TonB-dependent receptors, 
transitions that modify the conformation of the plug domain and/or barrel are 
required for transport. These changes are mediated by physical interactions between 
TonB and the TonB-box [31, 32, 33, 34], and possibly by periplasmic turns of the 
11 
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barrel [35]. Formation of a complex with TonB results in the transfer of stored 
potential energy to the receptor [36], which in turn promotes ligand transport. 
1.2.2.2 HasA Mediated Bacterial Haem Transport 
Haemophores are extracellular proteins that acquire haem either from haemopexin, 
such as HxuA [37] or from various haemoproteins, such as HasA [38]. HasA 
haemoproteins are produced by several Gram-negative bacteria. They form an 
independent family of haem-binding proteins without homology to any other known 
proteins. HasA stands for haem acquision ystem which forms an independent family 
of haemoproteins that take up haem from the host and shuttles it to specific receptors, 
HasR [39]. The receptor is essential for haem acquisition, whereas the haemophore is 
not, although synergy between the haemophore and its receptor reduces the minimal 
haem or haemoglobin concentration required for growth by 100-fold [40]. 
a 
	I £'Ast41 b 
I 
\% 	 His 83 
Jyr 75 
Figure 1.3 X-ray crystal structure of HasA. (a) View of the residues in the haem 
binding site. His 83 is presumed to be involved in both processes of haem capture 
and release. The residues and the haem are shown in ball-and-stick representation. 
The surrounding backbone is represented as a ribbon. (b) Backbone structure of 
HasA. Ribbon diagram with helices coloured in red and strands in blue. The ligands 
of the haem (His, Tyr) and the haem are shown in ball-and-stick representation. The 
surface occupied by the haem is transparent [43]. 
HasA from S. marcescens is a monomer (19 kDa) that binds b haem with a very high 
affinity and 1:1 stoichiometry. Both haem-free (apoprotein) and haem-loaded 
(holoprotein) HasA bind to HasR, suggesting a direct protein-protein interaction in 
8 
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the haem delivery mechanism. Haem iron in ho/o-HasA is in a low-spin ferric state 
and Fe is six coordinated at neutral pH [41]. The crystal structure of the holoprotein 
indicates that the haem is held by two loops and greatly exposed to solvent [42]. The 
iron atom is ligated by the N atom of histidine 32 on one side and by the phenolate 
of tyrosine-75 on the other [43]. This residue pair, histidine-tyrosine, is a rare pattern 
of b haem ligation, only observed in Chiarnydornonas chioroplast haemoglobin [44] 
and its various mutated proteins [45]. The phenolate of tyrosine-75 is also involved 
in a tight hydrogen bond with the N5 atom of histidine 83. Some results from mutant 
protein show that Fe-Y75 ligation is stronger than Fe-H32 ligation. Mutation of H83 
results in a significant loss of affinity, however, histidine-83 may become an 
alternative iron ligand in the absence of tyrosine-75. The triple mutant protein, 
H32A-Y75A-H83A, has no detectable affinity for haem at all [39]. 
Haemophores greatly facilitate haem acquisition via their specific receptors without 
being internalised with their ligand. Hence, haem uptake involves sequential steps: 
schematically (i) haemophore-receptor interaction; (ii) haem transfer from the 
haemophore to the receptor; and (iii) haem internalisation through the haemophore 
receptor channel. The investigations of mechanisms of these steps show that HasA 
binding to HasR involves protein-protein interactions and indicates that none of the 
haem-binding residues is required for this interaction [39]. Also, both apo- and holo-
HasA bind with the same affinity to a common or overlapping site on HasR. These 
findings suggest that the recycling of haemophores at the cell surface when haem has 
been taken up does not occur by a mechanism of apo-haemophore ejection and 
replacement by newly loaded haemophore molecules. A preferred mechanism is 
haem exchange from a free loaded haemphore to a receptor-bound apo-haemophore. 
This mechanism allowing haem exchange from a loaded haemophore to a cell-bound 
apo-haemophore could involve interaction between the two haemophore forms or 
could be a consequence of the cell-bound form having a higher affinity for haem. 
Vt 
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1 .2.2.3 Structure and Function of the Transferrin Receptor TbpA and TbpB 
The transferrin receptor consists of two types of subunits, TbpA and TbpB 
(transferrin-binding proteins A and B), both of which have the capacity to 
independently bind their ligand, human transferrin (htf) [46]. TbpA (100 kDa) is 
thought to be a porin-like integral membrane protein that is proposed to serve as a 
channel for the transport of iron across the outer membrane. TbpA shares sequence 
similarities with FepA and FhuA [47]. Both proteins have been shown to form an 
antiparallel a-barrel [22, 481, and TbpA is thought to have a similar structure [49]. 
TbpB (65-85 kDa) is considered to be an outer membrane protein that is anchored to 
the membrane via the lipidated N-terminal part of the protein [50, 51]. 
TbpB has two different isotypes, both isotypes differ in their molecular masses: 
isotype I proteins have molecular masses of —68 kDa, whereas isotype II proteins are 
characterized by molecular masses of -80-90 kDa [52]. The apo-htf binding to 
TbpA was substantially stronger than the value obtained for the binding of holo-htf. 
TbpA has an affinity 20 times greater for apo-htf than holo-htf [53]. The mode of 
ligand binding is different for the two isotypes. The binding of holo-htf to isotype I 
TbpB is enthalpy-driven and opposed by an unfavorable entropy change. In contrast 
to the isotype I TbpB, the holo-htf binding to isotype II TbpB is driven by favorable 
entropy and enthalpy changes. The interaction of both TbpB isotypes with apo-htf is 
negligible. Furthermore, the number of binding sites (n) was found to be close to 1, 
confirming 1:1 stoichiometry for the binding of htf to TbpB [54]. When holo-htf 
binds to the mixture of TbpA and TbpB, it is found that a total of three holo-htf 
molecules are needed to saturate the receptor, contains one high affinity site and two 
low affinity sites. For TbpB, both N-ter (N-terminal domain of TbpB) and C-ter (C-
terminal domain of TbpB) were found to contain very little secondary structure; this 
means a large part of both proteins is present in a coil conformation. However, the 
secondary structure content of a stoichiometric mix of both domains was found to be 
higher to that of both domains on their own. This is evidence that the domain 
interaction is accompanied by structural rearrangements. No interaction between 
holo-htf and C-ter was observed. TbpB, N-ter and C-ter were found to bind TbpA. 
10 
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The binding of N-ter to TbpA is independent of its conformation; in contrast, C-ter 
binding to TbpA is conformation-specific [53]. 
1.2.3 ABC Transport Systems 
ABC (ATP-binding cassette) transport systems, consist of a soluble periplasmic 
protein, a transmembrane permease and an ATP-binding lipoprotein, and are used for 
the uptake of many different ligands [55]. These proteins share consensus sequences 
which identify them as belonging to a particular family [17] but they cannot replace 
each other in different systems. In addition to those systems for transporting iron and 
iron complexes, similar ABC transport systems are found for amino acids, peptides, 
sugars, and other essential nutrients [16]. 
Although the periplasmic proteins in ABC transport systems share very little 
sequence homology and recognise diverse ligands, most are closely related in 
structure [18]. Periplasmic proteins can be grouped into distinct classes based on 
similarities in primary sequence [17]. Many consist of two globular domains 
connected by short stretches of polypeptide chain, which allow movement of the two 
lobes by a hinge mechanism. Each lobe consists of a central fl-sheet flanked by a-
helices, and molecular recognition of ligands arises from slight differences in the 
number and arrangement of the fl-strands and a-helices in the two globular domains. 
As a result of the differences in domain structure and sequence of the periplasmic 
receptors, the structure of the binding site is highly variant. In most periplasmic 
proteins, cross-overs of the polypeptide chain between the two domains form the 
hinge region and the base of the binding cleft. The manner of closure around the 
substrate in the deep binding cleft formed by the two domains is suggestive of a 
"Venus fly trap" [56, 57] or "Pac-man" motion. This mode of binding gives rise to 
many interactions between the protein and substrate, conferring ligand binding 
selectivity to the protein [8]. 
The topology of typical periplasmic binding proteins is represented by the 
homologous iron-binding proteins FBP from N. gonorrhoeae and H. injluenzae [58]. 
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FBP can be described as "half transferrin". A detailed structural comparison between 
FBP and transferrin will be given in section 1.4. Although the nature of the amino 
acid side-chains coordinating the iron are similar in FBP and transferrin, they arise 
from different regions of the protein. The iron is also more solvent-exposed in FBP 
than it is in the transferrins, since the iron binding site is deeper within the protein 
and the loop covering the binding site is missing. As such, FBP shares more 
structural similarity with other anion-binding periplasmic proteins such as the 
phosphate-binding protein, sulphate-binding protein, maltodextrin-binding protein, 
and sperm idine-binding protein. Thus, the evolutionary descent of periplasmic and 
iron-binding proteins can be traced more accurately based on a combination of 
structural and sequence information (Figure 1.6). The apo form of FBP has the same 
overall fold but the two lobes of the protein are rotated by approximately 200  with 
respect to each other. Changes in the dihedral angles of the fl-sheets  lining the bottom 
of the binding site opens the binding cleft to the solvent [101]. 
Transport of ferric siderophores across the inner membrane is dependent upon the 
energy provided by respective cytoplasmic membrane-associated components. 
Studies of ABC transport systems for maltose and histidine show that only the 
ligand-loaded binding proteins initiate ATP hydrolysis [59], preventing wasteful 
hydrolysis. This implies that a signal from the periplasmic protein to the ATPase 
component of the ABC transport system must occur at some point to allow ATP 
hydrolysis [8]. 
1.3 Structure and Function of Transferrin 
The transferrins comprise a class of iron-binding proteins, which are known to be at 
least as ancient as the insects [60]. There are major classes of transferrins: serum 
transferrin, lactoferrins and ovotransferrins. They are all monomeric glycoproteins 
with an approximate molecular mass of 80 kDa, bind two ferric ions per molecule 
with high affinity, and have high sequence similarity. Serum transferrins or 
serotransferrins are responsible for the transportation of iron in serum and delivery of 
iron to cells via receptor-mediated endocytosis [61]. Ovotransferrins (formerly called 
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conalbumin) are found in avian egg whites and are identical to their serum 
counterpart except for their attached carbonhydrates [62], and are also capable of 
serving as an iron donor for immature erythrocytes in the avian embryo [63], but can 
not bind to mammalian receptors. Lactoferrins or lactotransferrins are found in 
numerous extracellular fluids and in the specific granules of polymorphonuclear 
lymphocytes and are known to be multifunctional, acting as antimicrobial agents 
[64], antifungal agents [65] and sequence-specific DNA-binding moieties [66]. 
Figure 1.4 A model of porcine serum transferrin showing the bilobal structure and 
domain arrangement whereby NI is equivalent to Cl (red and blue secondary 
structure) and Nil is equivalent to CII (green and cyan secondary structure). The 
liganded iron and carbonate of both lobes is shown. The N-acetyl glucosamine 
(NAG) that is covalently linked to Asn497 is shown in stick representation [67]. 
The three-dimensional arrangements of all the members of the transferrin family 
whose structures have so far been determined are fundamentally the same. Figure 
1.4 shows the structure of pST (porcine serum transferrin). The polypeptide chain of 
transferrin is disposed in two lobes, representing the N-terminal and C-terminal 
halves of the molecule. Each lobe of the transferrin structure is split into two 
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dissimilar domains (NI and Nil, Cl and CII in Figure 1.4) with a deep cleft in 
between where the Fe(III) cation is bound in conjunction with the synergistic 
carbonate anion. In both lobes the similar NI! and CII domains are formed from a 
continuous polypeptide separating the two regions that make up the similar domains 
NJ and Cl. It can be seen that each domain has a central mixed 13-sheet flanked on 
either side by a-helices. The folding of the domains is an approximate 13  I a repeat. 
Two antiparallel f3-strands connect the two domains of each lobe and form the hinge 
region about which the domain II pivots to give the open-lobe form of the apo 
protein. A short sequence connects both two lobes and takes the form of a helix in 
human lactoferrin and a 13-strand in rabbit serum transferrin [68]. 




Figure 1.5 The iron-binding sites of porcine serum transferrin: the overlay of the 
iron ligands of N-lobe and C-lobe, where the components of the N-lobe are in red 
and those of the C-lobe in blue [67]. 
The binding of iron by serum transferrin is sufficiently strong to resist hydrolysis 
[69], and it is physiologically reversible. The iron-binding sites in each lobe of 
porcine serum transferrin are very similar and comprise a distorted octahedral 
coordination involving four protein ligands, namely two tyrosines, a histidine, an 
aspartate and a bidentate synergistic carbonate anion. For pST, the protein ligands 
are Tyr94 and Tyrl 92 in the N-lobe (Tyr43 1 and Tyr526 in the C-lobe), His253 in 
the N-lobe (His594 in the Globe) and Asp62 in the N-lobe (Asp396 in the Globe). 
The aspartate residues have a dual role, they not only bind to iron, but also make 
hydrogen bonds with residues at the N-termini of a-helices, thereby helping to 
stabilise the lobe in closed conformation when metal is bound, but leaving it in an 
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open conformation in the absence of metal [70]. The synergistic anion of iron-
transferrin is carbonate, acting as a bridging ligand between protein and metal ion 
and completing the coordination needs of the metal ion. The carbonate is bidentate 
and binds between the iron and a positively-charged site on domain II of each lobe. 
When carbonate is absent, a variety of other bifunctional anions bearing at least one 
carboxylate group may take its place [71]. Iron is the most strongly bound metal to 
transferrin, however, human transferrin can accommodate a wide variety of other 
metals, more than 35 have been identified, metal ions with electron or nuclear 
paramagnetism have been especially valuable in probing the metal-binding properties 
of transferrins [4]. 
Numerous crystallographic structures of transferrins from the three major classes 
have been solved. However, relatively few precise structural data are available for 
the serum transferrins, the first solved being the diferric form of rST (rabbit serum 
transferrin) at a resolution of 3.3 A [72]. Other partial structures of serum transferrins 
include the N-terminal half domain from rST [73] and several recombinant N-lobe 
mutants of hST (human serum transferrin) [74, 75, 76, 77]. The structure of the 
human serum transferrin with Fe in the C-lobe only has also been reported at a 
resolution of 3.3 A [78]. A high resolution structure (2.15 A) of porcine serum 
transferrin shown above was reported recently [67], and it is a good example for the 
detailed structure of serum transferrin. 
Table 1.1 X-ray crystal structures of transferrins released in Protein Data Bank [79] 
PDB ID Source 	 Descriptor 
1A8E 	Homo sapiens 	Recombinant N-lobe of human transferrin reveals 
a structural change implicated in iron release 
(P21 21 2) 
IA8F 	Homo sapiens 	Same as 1A8E, but different space group (P41 21 2) 
1133E 	Homo sapiens 	Human serum transferrin, N-terminal lobe, 
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PDB ID Source 	 Descriptor 
expressed in Pichia pastoris 
1 BP5 	Homo sapiens 	Human serum transferrin, recombinant N-terminal 
lobe, apo form 
1 BTJ 	Homo sapiens 	Human serum transferrin, recombinant N-terminal 
lobe, apo form, crystal form 2 
1FQE 	Homo sapiens 	Mutant (K206A) that abolish the dilysine 
interaction in the N-lobe of human transferrin 
I FQF 	Homo sapiens 	(K296A) that abolish the dilysine interaction in the 
N-lobe of human transferrin 
1JNF 	Oryctolagus cuniculus Rabbit serum transferrin 
1JQF Homo sapiens Human transferrin N-lobe mutant H249Q 
IN7W Homo sapiens Human serum transferrin, N-Lobe L66W Mutant 
1N7X Homo sapiens Human serum transferrin, N-Lobe (Y45E) 
1N84 Homo sapiens Human serum transferrin, N-lobe 
1OQG Homo sapiens D63E mutant of the N-lobe human transferrin 
1OQH Homo sapiens R124A mutant of the N-lobe human transferrin 
1D3K Homo sapiens Two mutants (K206Q, H207E) of the N-lobe of 
human transferrin with increased affinity of iron 




PDB ID Source Descriptor 
1DTG Homo sapiens Human transferrin N-lobe mutant H249E 
1BOL Homo sapiens Recombinant human diferric lactoferrin 
1BIX Equus caballus Structure of diferric mare lactoferrin 
1BJY Bubalus arnee bubalis Structure of diferric buffalo lactoferrin 
1BKA Homo sapiens Oxalate-substituted diferric lactoferrin 
1BLF Bos taurus Structure of diferric bovine 
1CB6 Homo sapiens Structure of human apolactoferrin 
ICE2 Bubalus arnee bubalis Structure of diferric buffalo lactoferrin 
1 DTZ Carnelus dromedarius Crystal structure of camel apo-lactoferrin 
I EH3 Homo sapiens R2 10K N-terminal lobe human lactoferrin 
I17913 Mare colustru X-Ray structure of the complex of mare lactoferrin 
with melanin monomers 
1FCK Homo sapiens Structure of diceric human lactoferrin 
1H43 Homo sapiens R2IOE N-terminal lobe human lactoferrin 
1H44 Homo sapiens R21OL N-terminal lobe human lactoferrin 
1H45 Homo sapiens R21OG N-terminal lobe human lactoferrin 
1HSE Homo sapiens H253M N-terminal lobe of human lactoferrin 
116B Equus caballus Equine apolactoferrin 
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PDB ID Source 	 Descriptor 
116Q 	Camelus dromedarius An iron-saturated intermediate in the ferric iron 
binding pathway of camel lactoferrin 
1L5T 	Homo sapiens 	A domain-opened mutant (R121D) of the human 
lactoferrin N-lobe 
1 LFG 	Homo sapiens 	Diferric lactoferrin 
ILFH 	Homo sapiens 	Structure of apolactoferrin, a protein displaying 
large-scale conformational change 
ILFI 	Homo sapiens 	Crystal structure of human copper-lactoferrin 
1LGB Homo sapiens 	A legume lectin complexed with the human 
lactotransferrin N2 fragment, and with an isolated 
biantennary glycopeptide 
1 LGC Lathyrus ochrus 	A legume lectin complexed with the human 
lactotransferrin N2 fragment, and with an isolated 
biantennary glycopeptide 
1N76 Homo Sapiens Human seminal lactoferrin 
1QJM Equus caballus A complex of lactoferrin with Sm(III) 
1VFD Homo sapiens Human lactoferrin, N-Terminal lobe mutant 
(R121E) 
1VFE Homo sapiens Human lactoferrin, N-terminal lobe mutant 
(R121S) 
1 AIV Gallus gallus hen ovotransferrin, apo form 
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PDB ID Source Descriptor 
1AOV Anas platyrhynchos Apo duck ovotransferrin 
MOT Anas platyrhynchos Diferric duck ovotransferrin 
1GV8 Anas platyrhynchos 18 Kda fragment of N-li domain of duck 
ovotransferrin 
1 GVC Anas platyrhynchos 1 8Kda N-TI domain fragment of duck 
ovotransferrin + NTA 
1TEJ Gallus gallus Ovotransferrin, N-terminal lobe, holo form 
11Q7 Gallus gallus Ovotransferrin, C-terminal lobe, apo Form 
IJL4 Homo sapiens Human Cd4 N-terminal two domain fragment 
complexed to a class II mhc molecule 
IJL4 	Mus musculus 	Human Cd4 N-terminal two domain fragment 
complexed to a class II mhc molecule 
1JL4 	Gallus gallus 	Human Cd4 N-terminal two domain fragment 
complexed to a class II mhc molecule 
1NFT 	Gallus gallus 	Ovotransferrin, N-terminal lobe, iron loaded open 
form 
1NNT 	Gallus gallus 	pH-sensitive dilysine trigger in the hen 
ovotransferrin N-lobe 
1OVB Anas sp. 	 The structure of an 18 Kda Nil-domain fragment 
from duck ovotransferrin 
1 OVT 	Gallus gallus 	Diferric hen ovotransferrin 
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PDB ID Source 	 Descriptor 
ITFA 	Gallus gallus 	Ovotransferrin, N-Terminal lobe, apo Form 
1 TFD 	Oryctolagus cuniculus Rabbit serum transferrin - preliminary structure- 
analysis of the N-terminal half-molecule 
1H76 	Sus scrofa 	 Diferric porcine serum transferrin 
All nonhaem iron in the circulation is normally carried by transferrin. In disorders 
characterised by iron overload, such as transfusion-dependent thalassemia and 
hemochromatosis, nonhaern iron may also be found in the plasma. Such iron, largely 
as its complex with citrate [80], maybe more reactive and available than transferrin-
borne iron [81] and hence a threat to virtually all cells and tissues [4]. 
Although transferrin binds iron tightly at physiological pH, transferrin may 
relinquish Fe(III) to other molecules of biological interest. In the presence of citrate, 
intermolecular transfer of iron among transferrin molecules themselves can occur 
[82]. Ferritin is the major intracellular storage depot for iron, it is described as "bag 
of iron". Its hollow spherical structure can accommodate up to 4500 atoms of iron (as 
hydrated ferric oxide), deposited when iron is plentiful and released when iron is 
scarce. When ferritin is mixed with apo-transferrin, iron can be delivered from 
ferritin to transferrin, and the reaction rate is doubled by 1 mM citrate [83]. If the 
proteins are separated by a dialysis membrane, no exchange of iron is observed in the 
absence of a mediating agent, this reveals the importance of iron carriers in 
intracellular iron metabolism. Other proteins, like hemoglobin in the reduced, native 
state can accept iron from transferrin. Uteroferrin, with mediating agents such as 
citrate, pyrophosphate, ATP or ascorbate, can transport iron to transferrin 
unidirectionally [84]. 
Many important human pathogens, among them Haemophilus influenzae, Neisseria 
men ingitidis, Moraxella catarrhalis, and Neisseria gonorrhoeae, are capable of 
securing iron from transferrin or lactoferrin. To accomplish this, they elaborate a pair 
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of transferrin-binding proteins, TbpA and TbpB, or LbpA and LbpB, which act in 
concert to trap transferrin [13]. The pathogens are not known to elaborate 
siderophores, but effectively remove iron from transferrin by a process involving 
these transferrin receptors [85]. The primary site in the human transferrin molecule 
recognised by the bacterial receptors is in the C-lobe [86], as is the site for 
recognition by the human transferrin receptor. A soluble iron-binding protein in the 
periplasmic space of pathogenic Neisseria has a function in the delivery of iron from 
simple iron chelates to the bacteria [4]. 
1.4 Structure and Function of FBP from Neisseria Gonorrhoeae 
FBP is ferric ion binding protein. It is found in for example Haernophilus influenzae 
(hFB P), Neisseria gonorrhoeae, Neisseria ineningitidis (nFBP), Serratia marcescens 
(sFBP), Yersinia enterocolitica (yFBP) [87, 88, 89, 90], and belongs to the 
superfamily of transferrin proteins, which encompasses the mammalian transferrin 
proteins [91]. 












Figure 1.6 Deduced evolutionary tree for selected members of the transferrin 
superfamily, based on comparison of structures and sequences. This tree combines 
the transferrins with periplasmic transport proteins in clusters I (sulphate- and 
phosphate-binding) and VI [Fe(III)- and maltodextrin- binding] based on the analysis 
of Tam and Saier [17]. Clusters II, III, and IV of the prokaryotic periplasmic 
transport proteins are also related by evolutionary descent, based on the topological 
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similarity of known crystal structures, but may lie outside the pattern shown here 
[58]. 
FBP is a periplasmic binding protein, it is a convergent nodal point for Fe(III) 
trafficking subsequent to a variety of very different transport strategies across the 
outer membrane [92]. Recombinant FBP (rFBP) has been cloned and overexpressed 
in Escherichia coli, allowing for its efficient purification in near-gram quantities 
[94]. Wild-type FBP is pink and the molecular mass is 33 606 Da [93]. It is a basic 
protein (p1> 9.35) comprised of 309 residues [94, 95]. One FBP molecule is thought 
to bind only to one ferric ion [96]. Circular dichroism analysis of purified FBP 
indicates an a-helix/fl-sheet content of 32/27% [97]. 
Figure 1.7 Crystal structure of holo-FBP from Neisseria gonorrhoeae (left), and its 
metal binding site (right). Tyr195, Tyr196 (yellow), His9 (blue), G1u57 (red), 
phosphate and a water bind to Fe(III) with octahedral geometry [98]. 
In FBP, six ligands coordinate the Fe(III) with nearly ideal octahedral geometry. The 
protein itself contributes tyrosinate oxygen ligands from Tyr195 and Tyr196, a 
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carboxylate oxygen ligand from Glu 57, and an imidazole nitrogen ligand from His 
9. Two additional oxygen ligands are provided by a water molecule and an 
exogenous phosphate ion (Figure 1.7). 
FBP is critical for the transport of growth-essential Fe(III) from the periplasm into 
the bacterial cytosol [99]. It is characteristic of the well-described class of 
periplasmic binding proteins, but is unique in that it functions in the transport of iron 
[100]. The function of FBP is summarised in Figure 1.8. The transportation of the 
Fe(III) into the bacterial cell requires the direct interaction of the host protein and a 
bacterial surface-associated Tf or Lf receptor. Pathogenic bacteria express Tf and Lf 
receptors that bind the host iron-binding proteins with micro-molar affinities, 
whereupon iron is extracted directly from Tf or Lf [51]. This step is typified by 
binding Tf to the bacterial heterodimeric receptor complex consisting of transferrin-
binding proteins TbpA and TbpB [101]. 
ufI 
CM 
Figure 1.8 Model of iron transport from transferrin to the cytosol in pathogenic 
Neisseria and H. influenzae [103]. 
The process by which the iron is extracted from Tf and shuttled across the outer 
membrane and into the periplasmic space remains largely undescribed. However, an 
energy source mediated by TonB and associated proteins (ExbB and ExbD) is 
generally considered to be required [102]. After transport across the outer membrane, 
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free iron associates with the periplasmic Fe(III) binding protein FBP [89]. Transport 
of iron from FBP across the cytoplasmic membrane is accomplished using a free-iron 
ABC transporter, consisting of a genetically linked permease and ATP binding 
protein [90, 103]. Cytoplasmic iron is then assimilated directly into iron-coordinating 
proteins or prosthetic groups (e.g., haem), or is stored in the form of bacterioferritin 
[104]. 
Transferrin and FBP operate in different compartments (serum vs periplasm) and 
have arisen through separate evolutionary lineages, However, FBP is structurally and 
functionally analogous to one lobe of transferrin without sequence homology [96, 
58]. Nevertheless, there are crucial differences in iron binding between FBP and 
transferrin. The coordination of the iron by the oxygens of two tyrosines, an 
imidazole nitrogen from histidine are the same for FBP as for transferrin, but FBP 
completes the octahedral coordination of Fe(III) with oxygens from a glutamate, 
phosphate and a water molecule, whereas transferrins utilize the oxygen from an 
aspartate and two oxygens from a carbonate anion [58], and no water molecule is 
involved in Fe(III) binding in transferrin. Although similar amino acid residues are 
used to bind Fe(III) in both FBP and transferrin, the residues come from different 
parts of the polypeptide chain, this suggests that FBP and transferrin are descended 
from an iron-binding common ancestor [58]. 
Table 1.2 Comparison of properties of hTf, hLf, and Fbp [96] 
Characteristic Transferrin Lactoferrin [105] FBP 








Fe(III)-binding sites 	 two, one per lobe two, one per lobe one 
UV-Vis, '1ax  [Fe(Ill)-bound] 	470 nm 	 460 nm 	 481 nm 
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The transferrins can efficiently bind metals other than iron, including Al(III), Ga(IIl), 
Cu(II), Zn(II), Cr(III), and Tb(III), among a total of 35 elements [105]. Due to the 
structural and functional homology of FBP and transferrin, based on the previous 
research on transferrin, binding of apo-FBP to some other metals has been 
investigated [96, 107]. The results suggest that the same range of metal binding can 
occur within FBP that is characteristic of the transferrins. 
1.5 Aims of the Project 
The aims of this work were as follows 
To prepare recombinant FBP and investigate methods for reconstituting with 
iron, and especially the possibility that FBP may bind clusters of iron atoms. 
To investigate the possibility that Hf(IV) can bind to FBP and replace Fe(111) 
from FBP and therefore to be a candidate metalloantibiotic. 
To study the binding of vanadate to FBP and the possibility that vanadate can 
not only bind to the Fe(III) site, but also mimic the binding of phosphate. 
A particular aim of this project was also to crystallise novel metal adducts of FBP for 
X-ray structural determination. 
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2.1 General Reagents 
All chemicals and solvents were purchased from Sigma-Aldrich, Fisher, Acros, 
Pharmacia, Promega, Bio-Rad or Invitrogen unless specified in later chapters. 
2.2 Solutions and Buffers 
Ampicillin: a stock solution (100 mg/ml) was made and filtered by 0.2 Am filter. A 
final concentration of 100 g/ml was used in various media. The stock solution was 
stored at 4°C. 
Ethidium Bromide: a stock solution (10 mg/nil) was made and used at a final 
concentration of 5 itg/ml. The stock solution was stored in a dark bottle at 4°C. 
SDS running buffer: Tris-HC1 (25 mM, pH 8.3), glycine (192 mM), SDS (1% w/v). 
SDS sample buffer: Tris-HC1 (0.5 M, pH 6.8, 1.0 ml), glycol (2.0 ml), SDS (10% 
w/v, 1.6 ml), 2--rnercaptoethano1 (0.4 ml), bromophenol blue (0.05%, w/v, 2.0 ml). 
TAE (Tris-Acetate-EDTA) buffer: The 50 x stock TAE buffer was obtained from 
Bio-Rad. After being diluted with deionised water, the TAE buffer (1 x) contains 
Tris-HCI (40 mM), acetic acid (20 mM), EDTA (1M), pH 8.3. 
Physiological buffer - 100 mM NaCl, 4 mM NaH2PO4 and 25 mM NaHCO3, 
dissolved in water and adjusted to pH 7.4. 
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2.3 Media 
Agar plates: bacto-agar (15 gIl) was added to specified media with appropriate 
antibiotic to prepare agar plates. 
Luria Bertani (LB): bacto-tryptone (10 g), bacto-yeast extract (5 g), sodium 
chloride (10 g) were dissolved in 1 litre of deionised water and then the pH was 
adjusted to 7.5 using sodium hydroxide. 
S-Gal/LB/amp plate: a pack of SGa1TM/LB Agar Blend (Sigma C-4478) was 
dissolved in 500 ml water and autoclaved, then ampicillin was added to the solution 
to prepare plates. 
SOC: bacto-tryptone (20 g), bacto-yeast extract (5 g), sodium chloride (0.5 g), 
magnesium chloride (5 g), and glucose (3.2 g) were dissolved in I litre of deionised 
water and then the pH adjusted to 7.5 using sodium hydroxide. 
2YT (2 x YT medium): bacto-tryptone (16 g), bacto-yeast extract (10 g), and 
sodium chloride (5 g) were dissolved in 1 litre of deionised water and then the pH 
was adjusted to 7.5 using sodium hydroxide. 
2.4 Bacterial Cell Lines 
Escherichia coli TOP 1 OTM  (Invitrogen) cell lines were used for the storage of genes, 
for the initial transformation of ligation products, and also for overexpressing 
proteins. 
2.5 Storage of Bacterial Stocks 
LB or 2YT medium containing the appropriate antibiotics were used for the short-
term storage of E. coli. Colonies of bacteria were stored on inverted parafilm sealed 
agar plates at 4 °C for up to one month. For long-term storage, strains were frozen at 
—80 °C in LB or 2YT media containing 15% glycerol. 
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2.6 Overexpression of FBP in E. coil 
2.6.1 DNA Plasmid of Wild-Type FBP 
The plasmid pTrc99A containing the gene for FBP from Neisseria gonorrhoeae 
(pTrc99A/FBPNG) was supplied by Professor R.T.A. MacGillivray (University of 
British Columbia, Vancouver, Canada). 
2.6.2 Transformation of E. coil Competent Cells with Recombinant DNA 
The competent cells were gently suspended by tapping and 25 ftl of the suspension 
was transferred to a sterilised Eppendorf tube. It was left on ice for 30 minutes and 
the expressing plasmids (pTrc99A/FBP/NG) were added (up to 40 ng). Then, the 
cells were heat-shocked at 42 °C for 30 seconds, and then left to sit on ice for 2 
minutes. After that, 250 Id SOC was added. The mixture was incubated by shaking at 
250 rpm at 37 °C for 1 hour. Then, the suspension (30 Al) was spread to dryness on 
selective agar plates and incubated at 37 °C for 16 hours. 
2.6.3 Small Scale Preparation of FBP from E. coil 
A single colony from a freshly-transformed agar plate was transferred for growing in 
10 ml of 2YT containing 100 ,ag/rnl ampicillin at 37 °C for 16 hours. The cells were 
harvested by centrifugation at 3,000 rpm at 4 °C for 15 minutes. The best-expressed 
cells (the darkest pink colour) were picked out for large scale preparation of FBP. 
2.6.4 Large Scale Preparation of FBP from E. coil 
The cells from a small scale preparation were re-suspended with 2YT solution and 
each 1 ml of re-suspended solution was transferred to 250 ml LB containing 100 
g/ml ampicillin. The mixture was incubated by shaking at 37 °C for 18 hours. The 
cells were harvested by centrifugation at 10,000 rpm for 15 minutes. The pink wild-
type FBP pellet was collected and frozen at —20 °C for further protein extraction and 
purification. 
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2.6.5 Wide-type FBP Purification 
Wild-type FBP was purified by a slight modification of methods described 
previously [1,2]. The pellet from the large scale preparation (ca. 5 g) was defrosted at 
room temperature and was re-suspended in 50 ml of I M Tris (pH 8.0) and 50 ml 2% 
CTAB (Cetyltrimethylammoniurn Bromide, Aldrich, Cat, No. 85582-0). EDTA-free 
anti-protease tablets (Complete®, Roche, Cat. No. 1873580) were added followed by 
stirring gently for 6 hours at 37 °C. The white insoluble materials were removed by 
centrifugation at 10,000 rpm at 4 °C for 15 minutes. The supernatant was diluted by 
deionised water to a final volume of 1 litre and incubated at 4 °C for over 16 hours. 
Any insoluble material was removed by centrifugation (10,000 rpm, 4 °C, 15 
minutes), followed by ultrafiltration with a 0.45 p.m membrane, A RESOURCE®S 
column (6 ml, Pharmacia) was washed according to the manufacturer's instruction 
and equilibrated with 10 mM Tris buffer (pH 8.0, buffer A). The CTAB extract was 
centrifuged at 10,000 rprn for 15 minutes at 4 °C and filtered through a 0.45 p.m 
membrane, and then loaded onto the column by FPLC (Pharmacia) and the protein 
was eluted with a NaC1 gradient from low to high salt concentration (0-1 M) using a 
10 mM Tris, 1 M NaCl buffer (pH 8.0, buffer B). Parameters of the loading method 
and elution method are listed in Table 2.1. Fractions (4 ml) were collected and 
analysed by SDS-PAGE. FBP-containing fractions were pooled and concentrated by 
ultrafiltration (Amicon concentrator 30, 30 kDa cut-off) and purified on a HiLoad 
Superdex 200 column (26/60, Pharmacia) by elution with 10 mM Tris, 100 mM 
NaCl buffer, pH 8.0. 
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Table 2.1 FPLC methods for FBP purification using a RESOURCE®S column (6 ml) 
Loading Method Eluent Method 
Volume (ml) Parameter Value Volume (ml) Parameter Value 
0.00 CONC %B 0.0 0.00 CONC %B 0.0 
0.00 ML/MIN 4.00 0.00 ML/MIN 4.00 
0.00 PORT.SET 6.0 0.00 PORT.SET 6.1 
0.00 VALVE.POS 1.1 0.00 VALVE.POS 1.1 
250.0 CONC %B 0.0 90.0 CONC %B 0.0 
210.0 CONC %B 100 
240.0 CONC %B 100 
240.0 CONC %B 0.0 
270.0 CONC %B 0.0 
2.7 apo-Fbp Preparation 
Apo-Fbp was prepared by a modification of a published method [3]. Ten volumes of 
0.25 M citric acid solution (pH 4.5) were added to the holo-Fbp solution. This was 
kept at room temperature for half an hour, and then loaded on to a PD-10 column 
(Pharmacia). The protein was eluted with 0.25 M citric acid buffer (pH 4.50). Then 
the buffer was changed from 0.25 M citric acid to 10 mM ammonium acetate using a 
PD-10 column, followed by dialysis of the collected fraction against 10 mM 
ammonium acetate (5 litres), three times (10 hours each time). Finally, the protein 
solution was treated by Chelex®  100 resin to remove any trace metal, followed by 
lyophilisation. The apo-FBP powder was stored at -20 °C. 
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2.8 Protein Crystallisation 
Proteins consist of long macromolecule chains made up from 20 different amino 
acids. The chains can be several hundred residues long and fold into a 3-dimensional 
structure. It is therefore quite understandable that protein molecules have irregular 
shapes and are not ideally suited to be stacked into a periodic lattice, i.e., a crystal. 
Protein crystals are thus very fragile, soft and sensitive to all kinds of environmental 
variations. Protein crystals contain on average of 50% solvent, mostly in large 
channels between the stacked molecules in the crystal. The interactions holding the 
molecules together are usually weak, hydrogen bonds, salt bridges, and hydrophobic 
interactions, compared to strong covalent or ionic interactions in mineral crystals. 
This explains the fragility of the crystals, but allows for the possibility of soaking 
metal solutions or even large enzyme substrates or inhibitors, into the crystals [4]. 
In order to obtain a crystal, the protein molecules must assemble into a periodic 
lattice. To a solution of the protein with a fairly high concentration (2-50 mg/ml), 
reagents are added that reduce the solubility close to spontaneous precipitation. By 
slow further concentration, and under conditions suitable for the formation of a few 
nucleation sites, small crystals may start to grow. Often very many conditions have 
to be tried to succeed. This is usually done by initial screening, followed by a 
systematic optimisation of conditions. Crystals should be a few tenth of a mm in each 
direction to be useful for diffraction experiments [4]. 
The most common setup to grow protein crystals is the hanging drop technique. A 
few microliters of protein solution are mixed with an equal amount of reservoir 
solution containing the precipitants. A drop of this mixture is put on a glass slide 
which covers the reservoir. As the protein/precipitant mixture in the drop is less 
concentrated than the reservoir solution, water evaporates from the drop into the 
reservoir. As a result the concentration of both protein and precipitant in the drop 
slowly increases, and crystals may form. There is a variety of other techniques 
available such as sitting drops, dialysis buttons, and gel and microbatch techniques. 
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Robots are useful for automatic screening and optimisation of crystallisation 
conditions [4]. 
The hanging drop vapor-diffusion method was used for protein crystallisation in this 
project. Purified and concentrated protein (- 350 M) and precipitant solutions 
(various concentrations of PEG 1450 and PEG 4000), 0.1 - 0.2 M KCI, 0.4 M 
malate/imidazole or imidazole/HC1 buffer, pH 6.5 - 8.0. The drop (10 p.1) of protein 
solution and precipitant solution (1 : 1, v/v) was placed on a siliconised cover slip 
(BDH, Cat. 406/0189/44) and placed upside down over a wax-coated well lip. The 
crystal was grown at 4 °C or 17 °C. In some cases, seeding was used to grow better 
crystals. Normally, a crystal suitable for X-ray diffraction was obtained two weeks 
after setting up the drop. 
2.9 Instruments 
2.9.1 UV-Vis Spectroscopy 
The UV/Vis spectrophotometers used in this project were Perkin Elmer Lambda 16, 
Perkin Elmer Lambda 20, Shimadzu UV-2501PC and Varian Cary 300 equipped 
with temperature control systems. 1 cm quartz cuvettes were used with 500 p.1 
working volume. Normally, only solvent was used as reference. 
A common application of UV-Vis spectroscopy is the determination of the 
concentration of a substance in solution if the extinction coefficient is known and the 
Beer-Lambert law is obeyed. Proteins and nucleic acids have characteristic 
absorbances at 280 nm and 260 nm [5]. Their concentrations can be determined from 
absorbance (A) at these wavelengths and the Beer-Lambert law (c = A280/€b, c is the 
protein concentration, E is the molar extinction coefficient at 280 nm [Mcm 1 ], b is 
the path length [cm]). 
For protein samples with known amino acid components, € can be roughly calculated 
using the number of Trp(NTrP) and Tyr(NTyr) residues and disufide bonds (N) in the 
protein as follows [6]: C280 = 5540NTrp + 148ONTyr + 134N 
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2.9.2 ICP-AES 
ICP-AES stands for inductively coupled plasma atomic emission spectrometry. The 
plasma is formed by argon gas flowing through a radiofrequency field where it is 
kept in a state of partial ionisation, i.e. the gas consists partly of electrically charged 
particles. This allows it to reach very high temperatures of up to approx. 10,000 °C. 
A plasma is an electrically neutral, partially ionised gas composed of ions, electrons 
and neutral species (atoms and molecules) of an inert gas which is maintained by an 
external field, and has sufficiently high temperature to atomise, ionise and excite 
most elements. A variety of inert gases such as argon, helium and nitrogen can be 
used to form analytically useful plasmas. Typically quoted plasma temperatures 
range from 7,000 to 10,000 K. At high temperature, most elements emit light of 
characteristic wavelengths which can be measured and used to determine their 
concentrations [7]. 
The sample is introduced into the plasma as a fine droplet aerosol. Light from the 
different elements is separated into different wavelengths by means of a grating and 
is captured by light-sensitive detectors, one for each element being analysed. This 
permits simultaneous analysis of up to 40 elements and ICP-AES is consequently a 
multi-element technique. ICP-AES generally gives significantly improved limits of 
detection for most elements. Detection limits are typically at the pg/I (ppm) level for 
aqueous solutions. 
All ICP-AES analyses in this project were carried out on a Thermo Jarrell Ash IRIS 
instrument. The R. F. power was 1150 watts, the nebulizer flow was 30 psi, the pump 
rate was 100 rpm and the purge time was 90 s. Commercially available atomic 
absorption standard solutions of hafnium (BDH), iron (Aldrich), phosphate (Aldrich) 
and sulphur (Aldrich) were diluted and used as standards. The protein samples were 
measured without the digestion of samples. The standard concentration unit in ICP-
AES is ppm. The element codes, the slope of the standard line, and Y-int (the 
intercept of the standard line or zero-concentration) are listed in Table 2-2. 
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Typically, five standards were used, and the correlation coefficients was better than 
99.8%. 
Table 2-2 The emission lines used for ICP-AES analysis 
Element code 	Wavelength (nm) Slope 	 Y-int 
Hf 3399 339.980 (76) 24.02 0.3007 
Fe 2395 239.562(108) 27.82 0.5705 
P 2149 214.914 (121) 1.337 0.4920 
S 1820 182.034 (142) 0.7936 0.0341 
2.9.3 Nuclear Magnetic Resonance Spectroscopy 
Basic theory and concepts of NMR are given in various textbooks, such as Friebolin 
[8] and Mason [9]. The nuclei used in this project and their magnetic properties are 
given in Table 2.3. 
Table 2.3 Magnetic properties [10] of nuclei used in this project 
Nuclei 	 31 P 	 51V 
Nuclear Spin (I) 	 1/2 	 7/2 
Frequency(MHz)at 11.74T 	 202.4 	 131.5 
Natural Abundance (%) 	 100 	 99.75 
Magnetogyric Ratio y(107 rad T' s) 	10.83 	 7.05 
Nuclear quadrupole moment, Q (barn) 	- 	 -0.052 
In this project, the NMR instrument used was a Bruker DMX 500. All NMR spectra 
were recorded at 310 K. The solvent for protein samples was H20/ D20 ( 90% : 10%, 
v/v). Phosphoric acid (0 ppm) sealed in a capillary was used as external standard for 
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31P NMR, VOC13  (0 ppm), also sealed in a capillary, was used as external standard 
for 51V NMR. D20 (10%) was used for locking. The probe used for 31 P NMR was a 5 
mm triple-resonance probehead in multinuclear version TBJ probe (1 H, 31P, Broad 
Band), and the probe used for 51V NMR was a 5 mm BBO probe (Broad Band probe 
in the low frequency). 
2.9.4 Electron Paramagnetic Resonance Spectroscopy 
In electron paramagnetic resonance (EPR), also called electron spin resonance 
(ESR), electromagnetic radiation (usually of microwave frequency) is absorbed by 
molecules, ions, or atoms possessing electrons with unpaired spins, i.e. electronic 
spin S > 0. The sample material is immersed in a strong static magnetic field and 
exposed to an orthogonal low- amplitude high-frequency field. EPR usually requires 
microwave-frequency radiation (GHz). Energy is absorbed by the sample when the 
frequency of the radiation is appropriate to the energy difference between two states 
of the electrons in the sample, but only if the transition satisfies the appropriate 
selection rules. More details of the theory of EPR can be found in textbooks of 
Slicher [11] or Weil [12]. A Bruker ER 200D-SRC spectrometer (X-band) was used 
to record EPR spectra at 120 K using a liquid nitrogen insert Dewar and standard 
rectangular cavity. 
2.9.5 Crystallographic Data Collection and Structure Analysis 
X-ray crystallography is a technique that exploits the fact that X-rays are diffracted 
by crystals. It is not an imaging technique. X-rays have the proper wavelength (in the 
Angstrom range, _108 cm) to be scattered by the electron cloud of an atom of 
comparable size. Based on the diffraction pattern obtained from X-ray scattering by 
the periodic assembly of molecules or atoms in the crystal, the electron density can 
be reconstructed. Additional phase information must be extracted either from the 
diffraction data or by supplementing diffraction experiments to complete the 
reconstruction (the phase problem in crystallography). A model is then progressively 
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built into the experimental electron density, refined against the data and the result is 
an accurate molecular structure [13]. 
To perform an X-ray diffraction experiment, an X-ray source is needed. In most 
cases a rotating anode generator producing an X-ray beam of a characteristic 
wavelength is used. Intense, tunable X-ray radiation produced by a Synchrotron 
provides additional advantages. The primary X-ray beam is monochromated by 
either crystal rnonochromators or focusing mirrors. After the beam passes through a 
helium-flushed collimator, it passes through the crystal mounted on a pin on a 
goniometer head. The head is mounted to a goniometer which allows the crystal to be 
positioned at different orientations in the beam. The diffracted X-rays are recorded 
using image plates, multiwire detectors or CCD cameras (Figure 2.1). 
Flash cooling protein crystals to cryogenic temperatures (-100 K) offers many 
advantages, the most significant of which is the elimination of radiation damage. A 
part of the X-rays passing through the crystal are scattered in different directions into 
a detector. In our facility, multiwire detectors and CCD detectors were used. They all 
deliver an image of the diffraction spots. A large number of these images recorded 
from different crystal orientations are processed (scaled and merged) into a final list 
of indexed reflection intensities. 
Data for the protein crystals were collected and processed by Dr. Dmitriy Alexeev on 
DL 9.6 (SRS at Daresbury laboratory), the wavelength for data collection was 0.87 
A. For in-house data collection, a Enraf-Nonius FR591with MAR 345 Image Plate 
Detector was used. The wavelength for data collection was 1.54 A (K radiation of 
copper). All data were collected at 100 K. 
Data for the small hafnium complex [Na2Hf(NTA)2 H20] were collected by Dr. S. 
Parsons on a Bruker SMART ADEX CCD area detector diffractometer using 
graphite monochromated Mo Ka radiation ( = 0.71073 A). 



















4-Circle Gommieter (Eulerian or Kappa Geometry) 
Figure 2.1 Working principle of X-ray diffraction equipment [4]. 
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3.1 Introduction 
3.1.1 Iron in Biological Systems 
Iron is the fourth most abundant element in the earth's crust, the second most 
abundant metal besides aluminium [I]. The value of iron to biological systems is 
largely due to its incomplete filled orbitals giving two relatively stable oxidation 
states, namely iron(II) (d6) and iron(III) (d5), which provide a considerable range of 
reactivity for iron. The redox potential between these two states is such that 
oxidation processes centred on the iron can be coupled to metabolic reactions. Both 
ferrous and ferric forms can form salts with common anions. When bound to 
appropriate organic ligands, the reactivity of iron can be manipulated, allowing it to 
catalyse a wide range of chemical reactions essential to the cell. Iron is also the 
active component of the oxygen-carrier proteins. The necessity of sufficient iron for 
microbial metabolism is reflected by the almost universal requirement for the metal; 
only members of the genus Lactobacillus have replaced iron with other cofactors [2]. 
Iron can have a dual role in the life of a cell both as a protector from oxidation 
damage and as a destroyer by promoting such damage. Both iron insufficiency (by 
depressing the oxidative defences) and iron excess (by promoting the Fenton 
reaction) render cells at risk to damage from oxy-radicals [3]. The adult human body 
contains about 4 g of iron (i.e. 0.005% of body weight), of which about 3 g is in the 
form of haemoglobin, and this level is maintained by absorbing a mere 1 mg of iron 
per day-a remarkably economical utilization. 
Many proteins contain iron. Iron is found in a variety of different chemical 
environments in biology. Iron-containing metalloproteins fall into three main 
structural groups: A) Iron-sulfur proteins; this group of proteins contains one or more 
iron atom ligated by sulfide and thiolato sulfur. These proteins fulfill a variety of 
functions ranging from electron transfer and transport with both redox and non-redox 
roles, such as succinate dehydrogenase, nitrogenase, and aconitase. The iron can 
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exist in either or both of the oxidation states, +2 or +3. B) Haern proteins. It was 
known that Fe(IV) can be found in some haem proteins. The haem group is a 
common motif in biological systems and consists of an iron atom co-ordinated in an 
approximately square planar fashion by the pyrrole nitrogens of the porphyrin ring 
with one or two further axial ligands. The spin and the redox state of the iron 
influences the function of haem proteins leading to further subdivisions. I. Oxygen 
carriers such as myoglobin and haemoglobin where the iron is in the +2 oxidation 
state and cycles between a high-spin state and a low-spin electronic configuration. H. 
Oxygen activators such as peroxidases, oxidases and cytochromes P450 where both 
high and low spin states and oxidation states from +2 to +6 may be important. III. 
Electron transfer proteins such as cytochromes a, b, and c where the low spin 
configurations of iron in the +2 and +3 oxidation states are important. C) Non-haem 
and non-Fe/S proteins (metal loenzyrnes); this type of protein includes superoxide 
dismutase, dioxygenases, oxygenase, lipoxygenases, and ribonucleotide reductase. 
Iron may exist in the +2 or +3 oxidation states or both. Some iron-containing 
proteins found in nature are listed in Table 3.1 [4]. 
Iron is usually present in aqueous aerobic environments as insoluble ferric oxy-
hydroxides FeO(OH) [5]. At pH values approaching neutral, the maximum solubility 
of iron(III) is limited to 108  M due to its K,P  value of 10 	M4 [6]. Thus ferric ions 
are quickly hydrolysed to insoluble polymeric hydroxides. In contrast iron(II) is 
readily soluble (K=10 -17 M) corresponding to a maximum concentration close to 1 
mM at pH 7. Although ferrous salts are quite stable in the solid state, they are readily 
oxidised to the ferric form in solution in the presence of oxygen. It is thus obvious 
that under physiological conditions, neither iron(II) nor iron(III) is likely to exist in 
aerobic aqueous solutions as the hexa-aqua ions, [Fe(H20)6]2 and [Fe(H20)6]3 , to 
any appreciate extent. Only by the use of suitable ligands is it possible to keep 
iron(III) in aqueous solution under neutral and basic conditions. The low aqueous 
solubility of iron(III) at neutral pH has required the development of specialised 
methods for organisms to acquire the metal from their surroundings. Many micro-
organisms have evolved specific iron(III) sequestering agents, named siderophores, 
W. 
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in order to maintain the iron(III) in soluble form so as to facilitate the acquisition of 
the exogenous metal [6]. 
Table 3.1 Naturally Occuring Iron Proteins [4] 
Donor atoms, 	 No. of 
Name 	Stereochem 	
Approx.
istry 	Function 	Source 	 Fe 
Mol wt 
of Fe 	 atoms 
Haemoglobin 	5 x N Square 
pyramidal 
Myoglobin 	5 x N Square 
pyramidal 
Cytochromes 	5 x N + S 
or 0 (Tyr) 
or N (I-us) 
Octahedral 
llaem proteins 
02 transport 	Animals 
02 storage 	Animals 





NHIP (non-haem iron proteins) 
Transferrin 5 x 0, 1 x N Transport of Fe Animals 80000 2 
Ferritin FeO(OH) mineral Storage of Fe Animals 460000 20% Fe 
Ferredoxins 4 x S Distorted Electron transfer Bacteria, 6000- 2-8 
tetrahedral plants 12000 
Rubredoxin 4 x S Distorted Nitrogen fixation Bacteria 6000 1 
tetrahedral 
"MoFe protein" 4 x S Distorted Nitrogen fixation In nitrogenase 220000- 24-36 
tetrahedral 230000 
"Fe protein" 4 x S Distorted Nitrogen fixation In nitrogenase 50000- 4 
tetrahedral 70000 
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Siderophores are low molecular weight compounds which can chelate ferric ion with 
high affinity. They can solubilise iron from insoluble complexes of the metal and 
form six-coordinated octahedral complexes with ferric ions [7, 8]. The bacteria then 
acquire the iron through outer membrane receptor protein complexes. However, not 
all bacteria use a siderophore-mediated uptake process, including possibly Neisseria 
[9]. Gram-negative pathogenic bacteria acquire iron from the hosts lactoferrin and 
transferrin proteins by expressing receptors for these proteins (TbpA, TbpB, LbpA, 
LbpB) on their cell surface. Once the iron is deposited in the periplasmic space, 
Neisseria gonorrhoea and many other bacteria use FBP to facilitate transport of iron 
presented at the outer membrane across the periplasm to the cytoplasmic membrane. 
3.1.2 Conformational Differences Between apo-hFBP and ho/o-hFBP 
FBP is composed of two domains, with the iron-binding site occurring in a small 
cleft between the domains. The binding of Fe(III) by FBP is necessarily reversible, 
this means that FBP must be able to bind and donate iron and therefore exist in both 
metal-bound and metal-free conformations. The two domains of FBP move as rigid 
bodies about a hinge point located within the central 13-sheet connecting them [10]. 
Figure 3.1 Conformational change between apo-hFBP and holo-hFBP [11]. 
Figure 3.1 shows that for FBP from Haemophilus influenzae (hFBP), comparison of 
the apo-hFBP structure with that of holo-hFBP reveals a distinct change in the 
orientation of the two structural domains. Apo-hFBP displays a 210  hinge movement 
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of the two domains relative to the iron-loaded form of the protein. The C-terminal 
iron half-site (top) retains the same structure in both the apo and iron forms, 
including the presence of a phosphate ion (pre-existing complementarity), while the 
N-terminal half-site reorganises upon iron binding (induced fit) [11]. 
3.1.3 Anion of Fe-FBP 
As observed in the structure of holo-FBP, a monodentate tetrahedral phosphate is the 
synergistic anion of holo-FBP, although it has been found that a large excess of 
NaHCO3  increases the iron binding capacity of apo-FBP [12]. In addition, many 
other anions can also bind to Fe-FBP. When iron was reloaded to apo-FBP, it was 
found that NTA (nitrilotriacetiate), oxalate, and pyrophosphate also appear to serve 
as synergistic anions, but not sulfate or perchlorate. In addition, phosphate in holo-
FBP can be replaced by carbonate in the presence of a large excess of bicarbonate 
[13]. 
3.1.4 Summary of Studies in this Chapter 
FBP can bind iron reversely. In order to understand the mechanism of iron loading 
and release, apo-FBP was prepared, and the mononuclear complexes Na3 [Fe(NTA)2] 
and binuclear complex (Hpy)2[Fe2(cit)2(H20)7] were used to load iron into apo-FBP 
(from Neisseria gonorrhoeae). The reloaded Fe-FBP was characterised by ICP-AES, 
high-resolution chromatography and EPR. To investigate the function of residues 
which are involved in iron binding in holo-FBP, two mutant FBP proteins (E57H 
FBP and Y195H/Y196H FBP) were expressed and characterised. The possibility that 
Fe-FBP can cleave phosphoester bonds was also investigated. High-quality crystals 
of apo-FBP, mononuclear Fe-FBP and multinuclear Fe-FBP were prepared and the 
structures were investigated by X-ray crystallography. 
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3.2 Experimental Methods 
Chemicals 	Ferric nitrate, Fe(NO3)9H20, (Prod. No. 28384), polyethylene glycol 
4000 (Prod. No. 442734X), ammonia acetate (Prod. No. 10013) and tn-sodium 
citrate (Na3C6H507 2H20, Prod. No. 10242) were purchased from BDH. 
Nitrilotriacetic acid (Cat. No. N840-7), atomic absorption standard solution of Fe 
(Cat. No. 30595-2) and S (Cat. No. 33329-8), and bis(4-nitrophenyl) phosphate 
(BNPP) (Cat. No. 12394-3) were obtained from Aldrich. Imidazole (Cat. No. 1-2399) 
was purchased from Sigma. Citric Acid (Cat. No. C/6240/53), sodium chloride and 
sodium hydroxide were purchased from Fisher. Polyethylene glycol 1450 (Cat. No. 
41804-5000) was purchased from Acros. 
Starting materials Apo-FBP was prepared as described in Chapter 2. 
Na3[Fe(NTA)21-5H20 solution was prepared with Clegg's method [14]. Dinuclear 
Fe(Ill) complex (Hpy)2[Fe2(cit)2(H20)2]•2H20 was prepared with Shweky's method 
[15]. Both complexes were characterised by CHN analysis. 
UV-Vis (Ultraviolet-Visible) spectroscopy UV-Vis experiments were performed 
with a Cary 300 UV-Vis spectrometry using 0.5 ml of sample in 1 cm quartz cuvettes 
with temperature control unit. The spectra in this chapter were recorded between 700 
nm / 800nm and 220 nm. 
Preparation of holo-Fe-FBP 	Holo-Fe-FBP (no phosphate bound) was 
prepared by using 50 mM Tris buffer (pH 8.0) to wash holo-Fe-P-FBP (with 
phosphate bound) with 30 kDa molecular weight cut off Centricon® (YM-30, 
Millipore) for three times. 
Preparation of reloaded Fe-FBP Reloaded Fe-FBP was prepared by adding a 50- 
fold 	molar 	excess 	of 	iron(III). 	Either 	Na3[Fe(NTA)2] 	or 
(Hpy)2[Fe2(ci02(H20)2].21-120 was added to an apo-FBP solution in 10 mM Tris, 100 
mM NaCl, pH 8.0. The mixture was incubated in a 37 °C water bath for three hours, 
and low molecular weight impurities were removed using a PD-10 column 
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(Amersham), and then by ultrafiltration (Centricon®, 30 kDa cut off, YM-30, 
Millipore). 
Phosphoester bond cleavage by Fe-FBP Reloaded Fe-FBP was prepared as 
described above. The compound BNPP was mixed with Fe-FBP in 10 mM Tris, 100 
mM NaCl, pH 8.0 at 37 °C with 1: 1 molar ratio. The reaction was monitored by UV-
Vis spectra from 800 nm to 220 nm at 30 minute time intervals. To determine the 
rate constant, a 14-fold molar excess of BNPP was reacted with reloaded Fe-FBP in 
50 mM Tris, 0.1 M NaNO3, pH 8.0, at 37 °C. As control, a cuvette containing the 
same buffer and BNPP, but no reloaded Fe-FBP was used. 
Fe-FBP and DNA interaction 	The interaction between Fe-FBP and DNA 
(pUC18, Invitrogen) was investigated by 1% agarose gel and 6% DNA retardation 
gel (EC63652, Invitrogen). Linear PUC18 DNA was prepared by cutting circular 
pUC18 plasmid DNA with NdeI and purified by 1% agarose gel. Linear DNA was 
incubated with various concentrations of Fe-FBP in 50 mM Hepes, pH 7.5 in a 37 °C 
water bath for 3-24 hours. The protein-DNA interaction was examined with both 1% 
agarose gels and 6% DNA retardation gels. 
3.2.1 Site-Directed Mutagenesis of DNA 
Molecular biology reagents Restriction enzyme NcoI, Hindlil, NdeI and related 
buffers were purchased from New England BioLabs. TOPO TA cloning® kit was 
obtained from Invitrogen. DNA marker I and IV were purchased from Bioline. DNA 
sequencing kit (Big dye v3) was obtained from Biosystem. 
Electrophoresis of DNA (1% agarose gel) Agarose (1.44 g) was added to 120 ml 
TAE buffer and heated in a microwave oven at 100 °C until it was dissolved. The 
solution was cooled to 60 °C and 7 Al ethidium bromide (10 mg/ml) was added to the 
agrose solution. The gel was then poured into the casting mould and allowed to set at 
room temperature. 
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Electrophoresis of proteins NuPAGE® Noves 12% Bis-Tris Gel (NP0342) and 
related buffers were purchased from Invitrogen. 
Preparation and purification of plasmid DNA Plasmid DNA was prepared from 
cells as described in the QlAprep®  Spin miniprep Kit protocol (QIAGEN). Plasmid 
DNA was purified with a 1% agarose gel and then extracted from the gel using the 
QlAquick® Gel Extraction Miniprep Kit protocol (QIAGEN). 
The mutant gene for FBP/Y195HY196H was made by the PCR megaprimer method 
[16]. CACCAC were used as the mutant codons to change the TACTAC encoding 
Tyr-Tyr to His-His. Synthetic oligonucleotides were used as mutant primers for 
making the mutants. The mutagenic PCR reactions involve two PCR steps. 
Plasmid and oligonucleotide primer 	Plasmid for mutant protein FBPE57H 
was provided by Dr. Dominic J.B. Hunter. The primer for FBP Y195HY196H was 
purchased from Sigma Genosys. The sequences are shown below. 
FBPHisHis 5 '-ATCAACAACCACCACTGGCACGCT-3' 
FBP_Ng_For 5 '-CCATGGCAAAAACATCTATCCGATAC3' 
pTRC_His_Rev 5 '-TGTCTAATTTAGTCTTGCGTCTTC-3' 
Production of the Megaprimer (step 1) pTrc99A/FBP_NG (1 l) was used as 
template, FBP_HisHis as reverse primer (5 t1) and FBP_Ng_For as forward primer 
(5 i1), then 39 tl H20 was added to make the final volume to 50 l. The solution 
was overlayed with PCR oil and cycled 30 times at 95 °C for 1 minute, 58 °C for 30 
seconds, and 72 °C for 20 seconds. Finally, heating at 72 °C for 5 minutes to 
terminate the reaction. The PCR products were mixed with 5 1.11 blue loading dye and 
then applied on a 1% agarose gel and the band containing the target product was cut 
and purified. 
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Production of the Mutant FBP Gene (step 2) 	Megaprimer (15 j.tI) produced 
from step 1 was used as template, FBP_HisHis (1 tl) was used as reverse primer and 
FBPNgFor (5 tl) was used as forward primer, then 29 pA H20 was added to make 
the final volume up to 50 pA. The solution was overlayed with two drops of PCR oil 
and cycled 30 times at 95 °C for 1 minute, 58 °C for 30 seconds, and 72 °C for 60 
seconds. Finally, heating at 72 °C for 5 minutes to terminate the reaction. The 
product was analysed by 1% agarose gel electrophoresis. The band containing the 
target gene was cut and purified. 
Amplification of DNA 	PCR and sequencing reactions were carried out using a 
Perkin Elmer 480 thermal cycler. To a PCR tube (0.5 nil) containing two Ready to 
Go PCR 
T
" beads (Pharmacia), other components were added and the experiment was 
set up as described in PCR reaction step I and step 2. For the sample prepared for 
DNA sequencing, a PCR tube (0.5 ml) containing plasmid DNA (2 jil), primer (1 .tl, 
either PCR2.1 Rev 10 or PCR 2.1 FOR 10), Big Dye v3 (4 pA) and 13 pd H20 to 
make the final volume to 20 1.11. The mixed solution was covered by two drops of 
PCR oil and cycled 25 times at 96 °C for 30 s, 45 °C for 15 s and 60 °C for 4 minutes. 
The final product was transferred to a 1.5 ml Eppendorf tube for DNA sequencing by 
the service in ICMB (Institute of Cell and Molecular Biology, University of 
Edinburgh). 
TOPO Cloning 	The PCR products of mutant genes were cloned into PCR 2.1 
TOPO®  plasmids. This system provides a one step cloning strategy for the direct 
insertion of Taq polymerase-amplified PCR products into a plasmid vector. Taq 
polymerase adds a single deoxyadenosine (A) to the 3' end of a PCR product. The 
PCR2.1-TOPO vector supplied in the kit is linearised with single, overhanging 3'-
deoxythymidine (T) residue, so PCR can therefore ligate efficiently into the vector. 
By using this method, the PCR product of mutants was ligated into PCR2.1-TOPO 
and transformed into chemically TOPO competent cells to form the plasmid 
PCR2. 1/FBP NO (mutant). In this experiment, 4 pA inserted mutant FBP gene, 1 pA 
salt solution (from the TOPO cloning kit) and 1 tl TOPO vector were mixed in a 1.5 
ml Eppendorf tube. The mixture was left at room temperature for 30 minutes. After 
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this, 2 lid product from the last step was mixed with 25 jil TOP 10 cells, the mixture 
was sat in ice for 30 minutes, then in a 42 °C water bath for 30 seconds, and then sat 
in ice for 2 minutes. Then 250 j.il Soc was added to the solution and shaken at 250 
rpm at 37 °C for 1 hour. All solution was spread on a s-gal/LB/arnpicillin plate and 
incubated at 37 °c for more than 12 hours until the colonies were large enough. The 
white positive colonies were selected for small scale preparation to produce more 
plasmid DNA for DNA sequencing and the following experiments. The result of the 
cloning was examined by cutting gene inserted plasmid DNA with EoRI or NcoI, 
and then checked by a 1% agarose gel. 
Digestion of DNA with Restriction Endonucleases 	The required amount of 
DNA (2 jil, 0.5-1 fig) was treated with the appropriate amount of enzyme (1 tl) 
and buffer (2 l) and deionised water (13 lil). The sample was placed at the 
appropriate temperature for the required of time (buffer and temperature conditions 
for each enzyme as advised by the manufacturer). Typically, 2 pl blue loading dye 
was mixed with sample, which were subjected to electrophoresis on a 1% agarose 
gel. The gels were analysed and photographed under ultraviolet light. 
Cloning DNA Fragments into Expression Vectors 	The expression vector 
containing wild-type FBP gene (43 .il) was cut with NcoI (1 il) and HindlIl (1 I) in 
buffer 2 (5 Ill, New England BioLabs) to remove the wild-type FBP gene. Also, the 
mutant FBP gene was removed from the TOPO vector with NcoI and Hindlil. 
Expression vector (pTrc99A) and mutant FBP gene were purified on a 1% agarose 
gel. The mutant FBP DNA fragment (14 iLl), the host vector (4 iL1  pTrc99A), 10xT4 
DNA ligase buffer (2 Al) and T4 DNA ligase (1 Al,40,000 unit) were placed in an 
Eppendorf tube. A control using water (14 Al) instead of the gene or PCR product 
was also set up. The reaction was left at room temperature for 16-50 hours, and then 
the expression vector containing Y195HY196H FBP gene was purified on a 1% 
agarose gel. The purified DNA (4 iLl)  was transformed into 50 Al TOP 10 cells. 
Mutant FBP Expression Plasmid E57H FBP or Y195HY196H FBP was 
transfon-ned to TOP1O cells and the colonies were picked up for small scale 
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expression. For large scale expression, instead of using LB media, 2YT was used for 
mutant FBP expression. All other procedures are the same as wild-type FBP 
expression and purification as described in Chapter 2. 
3.2.2 Crystallisation of apo-FBP and Fe-FBPs 
Apo-FBP was crystallised using the hanging-drop method. The well solution was 
made from PEG 1450 30%, 0.4 M irnidazole/HC1 buffer, pH 7.2. The concentration 
of the stock solution of apo-FBP was 380 AM in 0.1 M KC1. The drop was a mixture 
of 5 gl well solution and 5 Al apo-FBP stock solution. The crystallisation tray was 
left in a 4 °C room and large crystals appeared after two weeks. 
Reloaded Fe-FBP was crystallised using the hanging-drop method. The well solution 
was made from PEG 4000 22%, 0.4 M Imidazole/HCI buffer, pH 6.9. Fe-FBP was 
made by reacting Na3[Fe(NTA)2] with apo-FBP solution as described above. The 
concentration of the stock solution of Fe-FBP was 400 ,aM in 0.1 M KCI. The drop 
was a mixture of 5 ttl vial solution and 5 jil Fe-FBP stock solution. The 
crystallisation tray was left in a 4 °C room and a large crystal appeared after two 
weeks. 
Cluster Fe-FBP crystals were prepared by soaking apo-FBP crystals in a drop 
containing (Hpy)2[Fe2(cit)2(H20)2]. High quality apo-FBP crystals were prepared 
freshly by introducing seeds from crushed old apo-FBP crystals to the saturated drop. 
The well solution (30% PEG 1450, pH 7.2) and the crystallisation drop were 
prepared as described before. After one week of seeding, apo-FBP crystals were 
harvested and stored in the vial solution. 
The stock solution containing Fe(III) dinuclear compound was made from 30% PEG 
1450, 0.4 M imidazole/HC1 buffer, pH 7.2, (Hpy)2{Fe2(cit)2(H20)2] was added to this 
solution, and the final concentration of (Hpy)2[Fe2(cit)2(H20)2] in the soaking stock 
solution was 10 mM. 
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The final soaking solution was prepared by mixing the stock soaking solution with 
well solution in the ratio of 30% : 70% (v/v). The apo-FBP crystals were transferred 
to the final solution and left at 17 °C overnight (16 hours). The colour of the 
crystals changed from colourless (before soaking) to brown (after soaking). 
E57H Fe-FBP was crystallised by the hanging drop method. The well solution is 
composed of2l% PEG 4000, 0.5 M irnidazole/HC1 buffer, pH 6.90 and 0.2 M NaCI. 
protein solution (5 Al) was mixed with 5 ,ul well solution. The crystallisation tray was 
stored at 4 °C, and the crystal appeared within two weeks. 
3.3 Experimental Results 
3.3.1 Overexpression of Mutant FBP 
The structure of wild-type FBP revealed that Fe(III) is six-coordinate with octahedral 
geometry. In order to investigate the function of some residues around the metal 
binding site in FBP, two FBP mutants were prepared. In the first mutant a histidine 
residue replaced Glu57; In the second mutant FBP two histidine residues replace 
Tyr 195 and Tyr 196. The purpose of the mutations was to investigate which residues 
play key roles in metal binding. 
Compared with wild-type FBP ( 100 mg/1), the yield of E57H Fe-FBP was low (-
20 mg/l). The colour of E57H Fe-FBP was red, and a strong LMCT band was found 
at 478 rim. This suggested that Fe(III) was bound to FBP. However, the yield of 
Y195H-Y196H FBP was high ( 100 mg/1), but this protein had no colour. The 
sample as isolated was analysed by ICP-AES, no metal was found in Y195H-Y196H 
FBP sample. Three bands were found in the SDS-PAGE gel as shown in Figure 3.2, 
but only a single peak was found by UV detection at 280 nm during the purification 
process on a gel filtration column. This suggested that this protein is not stable at 
room temperature, but is degraded to two small fragments. The size of two fragments 
suggested that the bond between H195-H196 might be broken. 
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Figure 3.2 SDS-PAGE gel of Y195H-Y196H FBP. The left diagram shows the 
collected fragments after the protein was purified by cation exchange 
chromatography at 4 °C. The right diagram is the mutant protein which was purified 
by gel-filtration column at room temperature. Lanes 12-18 are the collected 
fragments after purification by gel filtration chromatography. Lane 19 is the protein 
before purification by gel filtration. Lane 11 and lane 20 are apo-FBP, which was 
used as reference. Three main bands were found in the gel, which were marked as A 
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Figure 3.3 UV-Vis spectra of Fe-FBP reloaded using (Hpy)2[Fe2(cit)2(H20)2] (left) 
and E57H Fe-FBP as isolated (right). 
A broad charge-transfer band was found in both reloaded Fe-FBP and E57H Fe-FBP 
as shown in Figure 3.3. For the Fe-FBP made from Na3 [Fe(NTA)2], Am was found 
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at 463 nm, but if the starting material was (Hpy)2[Fe2(cit)2(H20)21, Am was found at 
450 nm. For E57H Fe-FBP, Amax was found at 478 nm. 
3.3.3 EPR Spectra Characterisation 
Holo-FBP, Fe-FBP reloaded by Na3 [Fe(NTA)2] and E57H Fe-FBP were 
characterised by EPR to compare their Fe(III) sites. 
- Holo-FBP 
- Reloaded Fe-FBP 
- E57H Fe-FBP 
I 	 I 
300 	 900 1500 	 2100 
Magnetic Field 
Figure 3.4 EPR spectra of holo-FBP (1 mM, dark blue line), reloaded Fe-FBP (0.4 
mM, pink line) and E57H Fe-FBP (0.4 mM, orange line) in 10 mM Tris, 100 mM 
NaCl, pH 8.0. Microwave frequency 9.49 GHz; microwave power 11.1 milliwatts; 
receiver gain 6.3x 1 04,  temperature -153 °C; conversion time and time constant, 500 
ms; sweep time 500 s. 
The Fe(III) binding environments in three proteins are quite similar (gholo-FBP  4.43, 
greloadFe-FBp 4.35 and gE57HFBp  4.32), the slight differences among the g values are 
due to small changes in the bound ligands of Fe(III) in different proteins. The EPR 
spectra confirm that the Fe(III) bound to FBP in the high-spin state in a weak field 
ligand site with low symmetry holo-FBP. Besides the concentration difference, the 
low intensity of signals from E57H FBP and reloaded Fe-FBP may be due to the 
low-spin state of bound Fe(III) ions in these proteins. 
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3.3.4 ICP-AES Analysis of Reloaded Fe-FBP 
Fe(III) was reloaded onto apo-FBP with Na3[Fe(NTA)2] in 10 mM Tris, pH 7.8. In 
addition, some phosphate was added to the reloaded Fe-FBP solution to observe the 
effect of phosphate in the process of Fe(III) binding to FBP. Holo- FBP was also 
mixed with Na3[Fe(NTA)2] to investigate whether more iron could be loaded on to 
holo- FBP. For both samples, excess Na3[Fe(NTA)2] was initially removed by a PD-
10 column, followed by ultrafiltration. The Fe/S/P ratio was determined by ICP-AES 
and three repeat measurements were made; the molar concentration of sulphur was 
used to assess the concentration of protein (one sulphur per protein molecule). The 
analysis results are shown in Table 3.2. Multiple iron binding was found over a wide 
range of conditions (salt concentrations, buffers, pH). Except for holo-native 
samples, all other samples were incubated in a 37 °C water bath before purification. 
Table 3.2 Analysis of Fe-FBP samples 
Sample 	Treatment 	 Mol element per mol protein 
Fe 	 P 
Holo-native As isolated 	 1.09 + 0.02 	0.10 + 0.03 
Apo/Fe 	50 x [Fe(NTA)2]3 , 10 mM Tris, pH 	2.4 ± 0.2 	0.05 + 0.08 
7.8 12 h 
Apo/Fe/l? 	10 x [Fe(NTA)2]3 , 10 mM Tris, pH 	1.8 + 0.1 	1.1 ± 0.1 
7.8, then 10 x phosphate, 1.5 h 
Holo/Fe 	10 x [Fe(NTA)2]3 , 10 mM Tris, pH 	1.10 ± 0.03 	0.20 ± 0.01 
8.0, 4 h 
* Molar excess (e.g. 10 x) is relative to protein concentration 
From the analytical result, it seems that there is no phosphate bound to holo-FBP 
although a bound phosphate was found in the crystal structure. This is due to the 
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extensive washing of the protein with 10 mM Tris-HCI, pH 7.8, which led to the loss 
of phosphate. Treatment of apo-FBP with excess chelated Fe(III) gave rise to 2-3 
mol Fe per mol protein. Because phosphate forms an insoluble compound with 
Fe(III), in the presence of phosphate, less Fe(III) was bound to apo-FBP than the 
sample in non-phosphate buffer, but a 1: 1 Fe: P ratio cannot be restored. Addition of 
a large excess of chelated Fe(III) to mono-ferric holo-FBP did not lead to additional 
binding of Fe, although the binding phosphate was removed. These results suggest 
that the reloaded Fe-FBP might have a different conformation from wild-type hub-
FBP. For hobo-FBP the binding cleft is closed when Fe(III) and phosphate bind to the 
protein and no more iron can gain access to the binding site. The binding cleft of 
reloaded Fe-FBP might be still open, so more iron(III) can bind to the protein. 
3.3.5 Characterisation of Fe-FBP by Chromatography 
Results from ICP-AES analysis revealed that the product of Fe(III) loaded to apo-
FBP is complex. The final Fe-FBP product might be a mixture of several forms of 
Fe-FBP. To characterise different forms of Fe-FBP, purified hobo-FBP and reloaded 
Fe-FBP in 10 mM Tris (pH 8.0) were loaded into a cation exchange Mono STM HR 
5/5 (Amersham) column. The elution rate was 0.5 mI/mm. The chromatograrns are 
shown in Figure 3.5 and Figure 3.6. 
In Figure 3.5, Two peaks were observed by detection at 280 nm, however, only one 
peak was observed at 480 nrn (the tyrosine to Fe(III) charge-transfer band). The main 
peak observed with absorption at both 280 nm and 480 nm was assigned to hobo-
FBP, and the small peak observed with absorption at 280 nm only was assigned to 
apo-FBP. This reveals that hobo-FBP isolated from cells is not saturated with Fe(III), 
but only one fonTn of hobo-FBP was found in solution. 
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Figure 3.5 Characterisation of holo-FBP by chromatography on a MonoSTM HR 5/5 
(Amersham) column. The left axis shows the absorption of holo-FBP at 280 nm and 
480 mn; the right axis is the percentage of buffer B (10 mM Tris, 200 mM NaCl, pH 
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Figure 3.6 Characterisation Fe-FBP reloaded with Na3 [Fe(NTA)2] by 
chromatography on a Mono 
STM 
 HR 5/5 (Amersham) column. The left axis shows the 
absorption of holo-FBP at 280 nm (blue) and 480 nm (red), the right axis is the 
percentage of buffer B (10 mM Tris, 200 mM NaCl, pH 8.0). The grey line indicates 
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Two main peaks were found for Fe-FBP reloaded with Na3[Fe(NTA)2]. Both peaks 
have absorption at both 280 nm and 480 nm, which means that there are two forms of 
Fe-FBP in the solution. Combined with the results from ICP-AES analysis, one of 
the peaks is assigned to mononuclear Fe-FBP, the other peak, to polynuclear Fe-FBP. 
3.3.6 Phosphoester Bond Cleavage by Fe-FBP 
Enzymes which hydrolyse phosphoester bonds frequently possess catalytic metal 
ions in their active sites and the metal ions most frequently employed are Mg2 , Zn2 , 
2+ 	2+ 	2+ 
Mn , Ca and Fe [17]. The DNA backbone is formed by phosphodiester links, 
ubiquitous chemical bonds in biological systems. So hydrolysis of DNA is an 
important enzymatic reaction, but exceedingly difficult to mimic due to the 
resistance of DNA to hydrolysis [18]. Metal complexes are well established as 
phosphodiester cleavage agents and in general their action is mediated by a powerful 
nucleophilic attack [19, 20]. It has been reported that a dinuclear iron(III) complex 
can cleave DNA under mild temperature and pH conditions [21]. 
Bis(4-nitrophenyl) phosphate (BNPP) is often used for studies of the 
phosphodiesterase activity of metal complexes. To test the enzyme activity of Fe-








Figure 3.7 The structure of bis(4-nitrophenyl) phosphate (BNPP) [22]. 
Reloaded Fe-FBP was prepared as described in Section 3.2. Bis(p-nitrophenyl) 
phosphate (BNPP, 10 mM stock solution) was mixed with Fe-FBP in 10 mM Tris, 
100 mM NaCl, pH 8.0 in a 1:1 molar ratio. The reaction was monitored by UV-Vis 
spectra at 37 °C from 800 nm to 220 nm in 30 minutes time intervals. Under the same 
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conditions, as a control, UV-Vis spectra were used to monitor any cleavage when 
BNPP was mixed with Na3[Fe(NTA)2], and between BNPP and the buffer solution. 
There was no reaction between either BNPP and Na3[Fe(NTA)2] or BNPP and 
buffer. In addition, no reaction was detected for holo-Fe-P1-FBP (Fe-FBP with 
phosphate bound) in 50 mM Hepes buffer, pH 7.5. However, the phosphoester bond 
of BNPP was cleavaged by Fe-FBP (either reloaded Fe-FBP or holo-Fe-FBP without 
phosphate). The phosphoester bond cleavage of BNPP by Fe-FBP yielded the 
product 4-nitrophenolate, which is yellow and has an absorption band at 400 nm. 
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Figure 3.8 UV-Vis spectrum for the reaction between BNPP and reloaded Fe-FBP 
(molar ratio 1:1, pH 8.0). Hydrolysis of BNPP was followed by production of the 4-
nitrophenolate anion, which is indicated by the increasing absorption at 400 nm. 
Figure 3.8 shows that BNPP can be hydrolysed by Fe-FBP although the reaction is 
quite slow. Under the similar conditions (50 mM Tris, 0.1 M NaNO3, pH 8.0) as in 
the experiment above (10 mM tris, pH 8.0), various amounts of BNPP were reacted 
with Fe-FBP at 37°C, monitored at 400 nm, and the results are shown in Figure 3.9. 
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Figure 3.9 Reaction of Fe-FBP (35 pM) with various concentrations of BNPP (100 
pM - 500 pM) . The reaction was monitored at 400 nm (diagram a), and a plot of the 
initial reaction rate of 35 jtM Fe-FBP versus different BNPP concentrations (100 pM 
- 500 itM) is shown in the diagram b. 
A large excess of BNPP was reacted with Fe-FBP to ensure pseudo first-order 
conditions. The extinction coefficient of 4-nitrophenol at 400 nm is C400 = 18700 L 
mor' cm-1  [23]; it was corrected to C400 = 18205 L moF1  cm-1  at pH 8.0. At the molar 
ratio of Fe-FBP : BNPP = 1:14 (Fe-FBP 35 tM, BNPP 500 j.tM), the reaction rate is 
6 x 10-6  mol U' s 1. Under the same conditions, it would take several weeks for 
BNPP to undergo self-hydrolysis. At pH 7.0 and 100 °C, the self-hydrolysis rate of 
BNPP in water is 3.9 x 10 10 [24]. Therefore Fe-FBP-catalysed hydrolysis is at least 
104 times faster than the self-hydrolysis rate of BNPP in water. 
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The phosphoester bond cleavage of BNPP by Fe-FBP suggested that Fe-FBP may 
cleave DNA under mild conditions. Linear PUC18 plasmid DNA was used in a 
reaction with Fe-FBP in 50 mM Hepes, pH 7.5. The mixture was examined with 1% 
agarose gel and 6% DNA retardation gel as shown in Figure 3.10. 
1 23 45 678 910 1213 
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Figure 3.10 Characterisation of the reaction between Fe-FBP and linear PUC18 
DNA on a 1% agarose gel (left) and 6% DNA retardation gel (right). In the agarose 
gel, lane 1 is DNA only, lanes 2 to 5 are various concentrations Fe-FBP (0. 1 LM, 0.2 
jiM, 0.5 jiM and I jiM) mixed with linear PUC18 DNA and incubated at 37 °C for 3 
hours. Lanes 6 to 9 are the same samples as lanes 2 to 5, but incubated at 37 °C for 
24 hours. Lane 10 is DNA marker I (Bioline, band size 10,000 200), lane 12 is 
ho/o-FBP (1 jiM) incubated with linear PUC18 DNA (37 °C, 24h), lane 13 is 
Na3[Fe(NTA)2] (200 jiM) incubated with linear PUG 18 DNA (37 °C, 24h). The same 
samples in the same order were loaded onto the 6% DNA retardation gel, but in lane 
25, the concentration ofNa3{Fe(NTA)2] was increased from 200 jiM to 600 jiM. 
There is no clear evidence for DNA cleavage in both gels because no bands for small 
fragment band are seen on the gel. However, with the increasing Fe-FBP 
concentration and increasing incubation time, the DNA band became more and more 
blurred, and the intensity of the DNA band became also weaker and weaker. With a 
large excess of Fe-FBP to DNA, a precipitate formed. There is no obvious shift 
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difference between free DNA band (lane 1 and lane 14 in Figure 3.10) and band for 
the the protein-DNA mixture (lanes 2-9 and 15-22). Compared with Fe-FBP, when 
much more concentrated apo-FBP mixed with DNA, there is no difference can be 
observed between apo-FBP-DNA sample and free DNA sample in the gel. As a 
control, no reaction between Na3[Fe(NTA)2] and linear PUC18 DNA was detected. 
Hence, the conclusion is that Fe-FBP cleavage of linear PUC18 DNA is not really 
detected under the conditions used here. This may be due to the steric effect of the 
DNA, the size of linear DNA is too large to access the small metal binding pocket of 
Fe-FBP, although for reloaded Fe-FBP, the binding cleft is open. However, Fe-FBP 
is highly positively-charged, and DNA is highly negatively-charged, so there can be 
a strong electrostatic interaction between them. This may explain why the DNA band 
became weaker under conditions of higher Fe-FBP concentration and longer 
incubation time. 
3.3.7 Crystallisation of apo-FBP and Reloaded Fe-FBP 
The crystallisation conditions for apo-FBP, mononuclear Fe-FBP were screened 
using commercially-available screen solutions from Hamilton Research( ' and 
Molecular Dimensions®. It was found that crystals only grew in PEG containing 
solutions. Further screening experiments were done at various pH values (pH 6.0 - 
pH 8.5), different PEG concentrations (12% - 35%), different temperatures (4°C and 
17°C) and with various types of PEG (PEG 400, PEG 1350, PEG 1450, PEG 3500, 
PEG 4000 and PEG 6000). 
In most cases, for both proteins, large needle crystals (looking like a pencil) were 
grown two weeks after setting up the crystallisation tray. The crystals are large, and 
they were very smooth and transparent, but only diffracted to 3.3 A maximum. A 
large unit cell was found for such kinds of crystals, which contains 25 molecules per 
unit cell. This made the structure determination work very difficult. Luckily, with the 
same crystallisation conditions, when the crystallisation tray was left at 4 °C, it 
happened once that some crystals with a new crystal form appeared two weeks after 
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setting up. This kind of crystal diffracted to higher resolution (1.5 A for apo-FBP and 
1.7 A for Fe-FBP), and the unit cell contained only 9 molecules. At other times, even 
at 4 °C, with the same crystallisation condition, only large needle crystals were 
produced. The apo-FBP crystal which diffracted at high resolution was crushed and 
used as seeds to produce more high resolution apo-FBP crystals for further soaking 
experiments. 
Figure 3.11 Apo-FBP crystals produced by introducing the seeds from crushed apo-
FBP crystals to fresh saturated crystallisation drops. The colour of crystals is due to 
the light polarisation. 
High-quality reloaded Fe3-FBP crystals cannot be prepared by co-crystallisation. So, 
the soaking method was used. First of all, high-quality apo-FBP was prepared as 
described in the experimental section; then it was soaked in a solution containing 
dinuclear iron(III) complex - (Hpy)2 [Fe2(cit)2(H20)2]. The colour of the crystal 
changed from colourless to brown-red (Figure 3.12), which means that iron was 
bound to apo-FBP during crystal soaking. 
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Figure 3.12 Apo-nFBP crystals soaking in a well solution containing the dinuclear 
(Hpy)2[Fe2(cit)2(H20)2] complex. The left picture was taken immediately after the 
apo-FBP crystals were introduced to the soaking solution, the right picture was taken 
after 90 minutes soaking. The colour of crystals in the right picture is much redder 
than the colour of crystals in the left picture; this reveals that after soaking, Fe(III) 
binds to apo-FBP. 
3.3.8 Crystal Structures of apo-nFBP, Fe-nFBP and Fe3-nFBP 
All three crystal structures were determined by Dr. Dmitriy Alexeev in ICMB 
(Institute of Cell and Molecular Biology) of The University of Edinburgh. 
Apo-nFBP Structure 	The crystal of apo-FBP from Neisseria gonorrhoeae 
diffracted to 1.9 A resolution. There are 9 molecules in the asymmetric part of the 
unit cell, and the interdomain hinges of all 9 molecules are open. Similar to the 
structure of apo-FBP from Haemophilus influenzae [11], a phosphate is specifically 
bound to the N-terminus of the helix which terminates in A1a141 and the phosphate 
oxygens are within 3-4 A of the oxygens of Tyr195 and Tyr196. At the metal binding 
sites of all 9 molecules, His9 and G1u57 are swung away, but the side-chains of 
Tyr195 and Tyr196 show versatile dynamic roles. One of the molecules in all 9 
molecules is different from the other 8 molecules in that Tyrl 96 also has partial 
occupancy of a site in which it is flipped towards the entrance of the binding cleft 
(Figure 3.13). 
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Table 3.3 Crystallographic data and refinement statistics. Numbers in parentheses 
are for the highest resolution shell. 
Parameter Apo-FBP Fe-FBP Fe3-FBP 
Wavelength (A) 1.54 1.49 1.54 
Resolution 1.80 1.80 1.77 
Refined twinning fraction (%) 30.1 44.0 44.1 
Completeness (%) 99.9 (99.7) 91.4 (64.1) 96.5 (87.1) 
I/.: 19.1 (5.2) 11.1 (1.2) 7.1 (2.1) 
Rsyll*(%) 5.4 8.5 11.7 
(%)/Rfree (%) 15.6/31.6 19. 1/35.2 16.7/30.0 
rms deviations 
Bonds (A) 0.007 0.007 0.006 
Angles (°) 1.22 1.32 1.15 
Average 13-factors 
Protein (A2) 29.7 43.1 39.8 
Water (A2) 35.3 37.6 35.8 
*Rsym = 	- <I,>/Ii, where <Ih> is the average intensity over symmetry equivalent 
reflections. tReyst = EIF, - F/ SF0, where summation is over the data used for 
refinement. 1 R ee  was calculated using 3% of data excluded from refinement. 
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Figure 3.13 (a) Crystal structure of holo-nFBP [25]; the interdomain cleft is closed. 
(b) Molecule A in the unit cell of apo-nFBP; the interdomain cleft is open; both 
Tyr195 and Tyr196 are pointing to the metal binding site, and a phosphate is bound 
to the N-terminal domain. (c) Molecule F in the unit cell of apo-nFBP. It is different 
from the other molecules in the unit cell. Tyr196 is flipped towards the entrance of 
the binding cleft, but the binding cleft is also open. (d) The binding site of molecule 
A of apo-nFBP. Phosphate forms hydrogen bonds with Tyrl 95, Tyrl 96, Ser139, 
A1a141, Asn175, and Asn193. (e) The binding site of molecule F of apo-nFBP. 
Tyr196 in this molecule is different from other molecules in the same asymmetric 
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Fe-nFBP structure The crystal of Fe-nFBP was prepared by co-crystallisation and 
diffracts to 1.9 A. The structure shows the presence of an open-cleft protein with a 
single Fe(III) bound only to Tyr195 and Tyr196, to NTA and water as ligands 
(Figure 3.14). Fe(III) is shielded by a chelating NTA ligand in much the same way 
as by bound EDTA in the recently reported Haemophilus influenzae Fe-(EDTA)-
FBP in which His9 had been mutated to Gin [26]. This structure reveals that open-
cleft mono-Fe-FBP can be formed and it is stable. 
Figure 3.14 Metal binding site of Fe(NTA)-nFBP. Fe is bound to both tyrosines in 
all nine molecules. The binding cleft is open. 
An open-cleft form of Fe-(N-lobe)ovotransferrin prepared by soaking crystals of the 
apo-protein with Fe-NTA has been reported [27]. It was said in the report that the 
open conformation was trapped by crystal packing forces, but in our case, the 
Fe(NTA)-nFBP crystal was obtained with co-crystallisation, so the cleft opening 
observed does not appear to depend on such forces. A similar structure reported 
recently is the 18 kDa NIT domain fragment of duck ovotransferrin-nitrilotriacetate 
complex, the Fe(III) is bound to the synergistic carbonate anion and only one 
tyrosine residue in a manner almost identical to the intact protein. The carboxylate 
groups and the tertiary amino group of the nitrilotriacetate occupy the remaining 
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Fe3-nFBP structure It seems that Fe3-FBP is the first example of an oxo tn-iron 
centre in a metalloprotein. Although the electron density does not reach atomic 
resolution, the maps clearly indicated the presence of tn-iron clusters. The 
orientation of the cluster in the metal-binding clefts of the nine molecules in the 
asymmetric part of the unit cell vary, but the overall shapes of all clusters are very 
similar and correspond well to Fe3013 tn-iron structural units. Examples of these 
clusters include [Fe90(cit)8(H20)3 ] [29] and Feigoxyhydroxide clusters [30]. Each 
cluster is situated in an open binding cleft, and contains a triangle of Fe(III) ions with 
each pair bridged by a L2-oxygen. There is a central 93-oxygen coordinated to all 
three irons. Three additional terminal oxygens coordinate to each Fe(III) of the 
tightly bridged Fe304 unit and complete the oxygen coordination shell of the 




a 	 b 
Figure 3.15 Binding site of Fe3-FBP. (a) Trinuclear oxo-iron cluster in molecule A 
of Fe3-FBP. Both Tyr195 and Tyr196 coordinate to the cluster. (b) Tninuclear oxo-
iron cluster in molecule F of Fe3-FBP. Tyr 196 is flipped out. 
Besides molecule F, the hydroxyl groups of Tyr 196 of all other molecules in the nine 
molecules in the asymmetric unit cell of Fe3-FBP are deprotonated and occupy the 
position of the central J.13-oxygen in the coordination sphere of the fri-iron cluster. In 
molecule F, Tyr196 is turned away from the cluster and the t3-oxide is recruited 
from water. The coordination of Tyr195 varies much more widely. In some 
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molecules (A, B, F, G, H, I), Tyr195 is deprotonated and directly coordinated to iron. 
In other molecules, Tyr195 forms a hydrogen bond with one of the terminal oxygens 
of the cluster in molecules D and E, and one of the bridging /i2-oxygens in molecule 
C. No citrate was found in Fe3-FBP although the starting material was an Fe-citrate 
complex. 
3.4 Discussion 
The results above show that the dityrosyl motif plays a dynamic role in the capture of 
oxo tn-iron clusters, which suggests that FBP could be involved in a novel mode of 
iron acquiring from oxohydroxy iron polymers and minerals. The structure of apo-
nFBP provides evidence of the versatile dynamic roles of the side-chain of Tyr195 
and Tyr196. Similar to the structure of Fe3-FBP, Tyr196 in molecule F of apo-FBP is 
also flipped towards the entrance of the binding cleft, suggesting a potential role for 
Tyr196 in guiding iron complexes into the cleft. 
The binding clefts in all three structures (apo-nFBP, Fe-nFBP and Fe3-nFBP) are 
open. However, the binding cleft of ho/o-Fe-P1 -FBP is closed. This means that after 
the metal is loaded onto the apo-FBP, phosphate controls the closure of the binding 
cleft. In the absence of phosphate, the binding cleft of iron FBP is open. Fe(III) in 
open-cleft FBP is accessible and potentially reactive. This is the reason why BNPP 
can enter the binding cleft and react with iron-FBP. However, in the holo form of Fe-
P1 -FBP, due to the closure of the binding cleft, BNPP cannot gain access to the iron, 
so no reaction could be detected. It will be interesting to investigate the reaction 
between iron FBP and various natural substrates. The open form of iron FBP shows 
phosphatase activity, which might be a way to acquire phosphate to close the binding 
cleft. The phosphatase activity provides a mechanism for signalling iron status, and 
coupling cluster breakdown and cleft-closure around a single iron. 
In a recent 2.5 A resolution x-ray study, crystals of outer membrane iron transporter 
apo-FecA soaked in ferric citrate at pH 8 appeared to capture diferric dicitrate itself, 
triggering a conformational change of the extracellular loops of FecA, and closing 
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the external pocket [31]. The formation of Fe3-FBP means that FBP could act as a 
periplasmic receptor for iron clusters taken up by FecA. In contrast to Fe-NTA-FBP, 
none of the oxo tn-iron clusters bound to FBP appears to contain bound chelated 
ligand (citrate). In the structure of (Hpy)2[Fe2(ci02(H20)2], two Fe(III) ions bridged 
by two alkoxide oxygen atoms of fully deprotonated citrate ligands [15]. The 
complex is stable in acidic solution at pH 2-3, in equilibrium with higher order 
clusters such as [Fe90(cit)8(H20)3]7  [29]. In 1:1 Fe(III) citrate solutions, citrate 
dissociates from Fe(III) at pH 4 and above, to give hydroxyl-iron polymers 
(particles) with citrate ions bound to the surface to prevent precipitation [32]. This 
chemical transformation could readily be observed by UV-Vis. The colour of the 
solution changed from yellow-green to red-brown at pH 8. The changing rate 
depends on the conditions. When strong hydroxide was added, the colour was 
changed immediately, when buffer was added, the colour was changed slowly. 
Exposure the solution to light also accelerated the colour change. 
Previously, it has been thought that iron is transported across the periplasm only as 
mononuclear centres. In this Chapter, the finding that iron oxohydroxide clusters can 
bind to FBP suggests that fragments of mineralised iron can also be transported. It 
has been found that FBP can access the outer surface of bacteria [33] and so the 
clusters could perhaps be acquired directly from the environment. Alternative 
pathways for cluster acquisition by FBP might involve sequential acquisition of iron 
from mononuclear transporters in the outer membrane, and in some bacteria, via 
FecA and diferric citrate recognition system. Studies of a wide range of bacteria 
should now enable exploration of these proposed iron transport pathways with 
potential for increased understanding of bacteria-mineral interfaces and virulence, 
and the design of novel antibiotics. 
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4.1 Introduction 
Hafnium has a similar chemistry to iron in water at physiological pH. With the aim 
of designing novel metal loantibiotics, hafnium is a good choice of hetero-metal for 
investigating the hctero-metal-FBP interactions. 
Hafnium has an atomic weight of 178.49 and its atomic number is 72. The electronic 
configuration is [Xe]4f 145d26s2, and atomic radius (empirical) is 155 pm [1]. There 
are six naturally occurring isotopes [2]: 
Isotope Natural Nuclear Isotope Natural Nuclear 
abundance spin (I) abundance spin (I) 
174 	H 0.16 0 178 H 27.28 0 
176 H 5.26 0 179Hf 13.62 9/2 
177 H 18.60 7/2 180Hf 35.08 0 
After the discovery of zirconium, on the basis of Bohr's theory, a new element was 
expected to be associated with zirconium. It was finally identified in zircon (ZrSiO4) 
from Norway, by means of X-ray spectroscopy analysis. It was named in honour of 
the city in which the discovery was made (Copenhagen). Most zirconium minerals 
contain 1 to 5% hafnium. The properties of hafnium are considerably influenced by 
the impurities of zirconium present. Of all the elements, zirconium and hafnium are 
two of the most difficult to separate. Their chemistry is almost identical. This is due 
in considerable measure to the effect of the lanthanide contraction making both the 
atomic and ionic radii (1.45 and 0.74 A for Zr and Zr4 ; 1.44 and 0.75 A for Hf and 
Hf) essentially identical. However, the density of zirconium metal is about half that 
of hafnium. Zirconium and hafnium, because of the larger atoms and ions, differ 
from titanium in having more basic oxides, having somewhat more extensive 
aqueous chemistry, and more commonly attaining higher co-ordination numbers, 7 
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and 8. They have a more limited chemistry of the 3+ oxidation state. Hafnium is 
resistant to concentrated alkalis, but at elevated temperatures reacts with oxygen, 
nitrogen, carbon, boron, sulphur and silicon. Halogens react directly to form 
tetrahalides [3, 41. 
4. 1.1 Co-ordination Chemistry of Hafnium 
The co-ordination chemistry of Hf involves many complexes with organic ligands. 
Cyclopentadienyl complexes Hf(IV) are especially common [5]. Generally, hafnium 
forms seven or eight co-ordinate complexes. 
Three Hf(IV) complexes have been used in previous work to study the interaction 
with transferrin. The structures of two of these complexes have been determined by 
X-ray diffraction, the other complex was characterised by JR and Raman. 
(NH4)2[Hf{N(CH2COO)3}2] is a stable complex in aqueous solution throughout a 
wide pH range [6]. The synthesis and the crystal structure of this complex were 
published by Held et. al. in 2000 [7]. The structure of the complex 
K4Hf(C204)4 5H20 was also determined by X-ray diffraction [8]. The complex 
K2[Hf(02)2(cit)]H20 has been synthesised and characterised by Dengel and Griffith, 
who found that this complex is stable only at pH values below 2 [9]. 
4.1.2 Biological Application of Hafnium 
Hafnium is a reactive metal closely related to titanium and zirconium. When Ti and 
Hf were evaluated as implant materials in a biological environment, there were no 
quantitative and qualitative differences in the tissue organisation detected between 
them. This means that Hf is an interesting metal for biomedical applications [10]. 
When administered orally, hafnium was not absorbed by digestive organs [11]. 
However, it was found that hafnium could react with blood components and transport 
proteins [12]. Because of its biological similarity to 239Pu, 181Hf was used as a non-a-
particle-emitting analog of Pu for metabolic, biochemical and selected human 
investigations [13]. In rats and hamsters, the radiohafnium organ distribution was 
skeleton> skin > muscle> liver at approximately 7 days postinjection. Biochemical 
Il 
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studies showed that the radiohafnium was bound mainly to the Fe-transport protein, 
transferrin, in blood plasma, and in the liver cytosol of both the rat and the hamster 
 
Several studies have been carried out to investigate interactions between hafnium and 
transferrin. One of them is the in vivo and in vitro studies of hafnium binding to rat 
serum transferrin. Three Hf(IV) complexes (Hf-NTA, Hf-oxalate and Hf-citrate) 
were used in these studies. The results show that with increasing percent iron-
saturation of the serum from 32% to 86%, the fraction of 181 Hf bound to the protein 
was reduced; in the presence of excess iron, none of the 181 Hf was bound to protein 
Each of the two metal sites in transferrin was able to bind hafnium [16]. 
Studies of the interaction between Hf(IV) and lactoferrin showed that the binding 
situation is quite similar to transferrin. The binding was also influenced by: a) the 
presence of phosphate; b) the pH of the buffer, and c) the temperature [16]. 
Table 4.1 The influence of iron on hafnium binding to rat serum proteins [15] 
Sample' 	
% Iron 	% total serum 181  Hf recovered in 
saturation 	 protein fraction 
181Hf-labelled rat serum A 	32 	 91 ± 3 
B 	84 	 17±4 
C 	150 	 <2 
Stable iron added to 181Hf- 	86 	 54 ± 12 
labelled rat serum (A) 
>200 	 <2 
aMeans  (±SEM) of three analyses per point. Hafnium concentration in serum: 3 VtM. 
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In experiments on Hf(IV) binding to transferrin, apart from the two specific binding 
sites, the authors suspected that there was a third binding site [15], which was not 
identical to the specific metal sites detected before [17]. The essential criterion for 
the specific binding of metals is the demonstration of competitive binding [18]. It 
was thought that because transferrin is optimised for the binding of iron, the binding 
strength of other metals to the specific sites is smaller by some orders of magnitude 
than that for iron [19]. 
4.1.3 Summary of Studies in this Chapter 
Due to the structural and biological similarity between FBP and transferrin [20], a 
mononuclear Hf(IV) complex Na2[Hf(NTA)2] 2H2O and Hf(IV)-citrate complex 
were synthesised and characterised, and then Hf(IV) was loaded to apo-Fbp and the 
reaction was investigated by UV-Vis spectra, ICP-AES, 31P NIMR and cation-
exchange chromatography. Finally, Hf-FBP was crystallised and the structure was 
determined by X-ray diffraction. To design novel metal lo antib i otics targeted on the 
bacterial periplasmic iron transport protein (FBP), Hf-FBP provides a good example 
of the hetero-metal interaction. 
4.2 Experimental Methods 
Chemicals 	Hafnium chloride (Prod. No. 293250250) was purchased from Acros 
Organics. Sodium bicarbonate (Cat. No. S-5761), and Hepes ([4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid], Cat. No. H3375), imidazole (Cat. No. 1-2399), malic 
acid (Cat. No. M-0875), nitrilotri acetic acid (NTA, Cat. No. N-8407), apo-transferrin 
(human, Cat. No. T-4382) and atomic absorption standard solutions of P (Cat. No. 
20735-7) and S (Cat. No. 33329-8) were obtained from Sigma-Aldrich. Sodium 
dihydrogen orthophosphate, sodium chloride and orthophosphoric acid (Prod. No. 
010450/PB08) were purchased from Fisher Scientific. Tr-sodium citrate (Prod No. 
10242), potassium chloride, plasma emission standard solution for Hf (Prod No. 
455442W) and polyethylene glycol 4000 (Prod. No. 442734X) were purchased from 
BDH. 
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pH measurements The pH values of the solutions were adjusted by NaOH or HC1 
and measured with a Coming 240 pH meter equipped with an Aldrich micro 
combination electrode. The calibration buffer solutions were purchased from Aldrich 
with pH values of 4.00, 7.00 and 10.01 (20 °C). 
UV-Vis spectroscopy 	All experiments were performed with 1 cm quartz 
cuvettes with a 0.5 ml working volume. The spectra were recorded from 600 nm to 
220 run, and reactions were monitored at 245 nm. 
Preparation of Na2 [Hf{N(C}12C00)3}2] 41120 This complex was prepared by a 
slight modification of Then's method [15]. HfCI4 was dissolved in 2M HCI. One 
mole of this solution was added to four moles of nitrilotriacetic acid (NTA) at 80 °C 
and neutralised by an appropriate amount of sodium bicarbonate at room 
temperature. The solution was heated to decrease the volume, and then cooled to 
room temperature. Large crystals appeared quickly. The product was recrystallised 
once from water. Fine single crystals, which were suitable for x-ray diffraction were 
obtained. Yield: 4.39 g, 73.1%. Four water molecules were found in the X-ray crystal 
structure, but after being dried in a desiccator, the complex lost two water molecules. 
Anal. Calcd (C12Hi 2HfN2Na2O 2 2H2O): C 22.64%, H 2.53%, N 4.40%. Obsd: C 
22.98%, H 2.60%, N 4.25%. 
Preparation of Hf(IV)-citrate complex 	Hf(IV)-citrate complex was prepared 
with Dengel and Griffith's method [21]. Reaction of the soluble oxychlorides 
HfOC1281-120 with sodium citrate (1:2 metal - ligand ratio) in a solution of 50% 
(v/v of 30% H202/H20) gave the complex with a possible structure 
Na2[Hf(02)2(citrate)]H2O because it was said that the pH of the complex formation 
was 2, a value low enough to suppress hydrolysis of the Hf(IV). The product was 
characterised by IR and proton NMR. 
Preparation of Hf-FBP 	Hf-Fbp was made from Na2[Hf(NTA)2] prepared in 
physiological buffer (4 mM phosphate, 25 mM NaHCO3, 100 mM NaCl, pH 7.40) 
using a molar ratio of Hf/apo-Fbp 4 : 1. The mixture of reactants was put into a 1.5 
ml Eppendorf tube and was incubated in a 37°C water bath for three hours. The 
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products were initially purified on a PD-10 column (Amersham), and then using 
ultrafilters (Millipore Centricon® YM-30) by 0.1 M KC1 for six times. Reaction with 
either 50 or 100 molar equivalents of Na2[Hf(NTA)2] gave similar products. 
Preparation of Hf-transferrin 	The powder of human apo-transferrin was 
dissolved in 10 mM Tris buffer, pH 8.0. Then 30-fold molar excess of 
Na2[Hf(NTA)2] was added into the protein solution, the mixture was incubated in a 
37 °C water bath for 16 hours. Excess Na2[Hf(NTA)2] was removed on a PD-10 
column, and then by ultrafiltration using a 30 kDa molecular weight cut off 
Centricon® (YM-30, Millipore). 
Inductively Coupled Plasma Atomic Emission Spectrometry (ICP-AES) 
Hf-FBP was purified with the procedure above in 10 mM Tris buffer (pH 8.0) 
instead of 0.1 M KC1. The commercially available hafnium standard atomic 
absorption solution was diluted with 10 mM Tris buffer. Total protein concentration 
was determined from the sulphur concentration (1 sulphur per mol protein: Met 308). 
Values are averages of three determinations on each sample. 
3l 	NMR of Hf-FBP The 3 1  P NIMR spectra was recorded at 202.4 MHz at 310 K on 
a Bruker Advance 600 spectrometer using a 5 mm BBO probe. Data for Hf-FBP 
were collected using a pulse width of 8.55 fts (60°) at 0.00 dB, relaxation delay 2 s, 
16,384 data points and 16,896 transients. The spectral width was 40 ppm and the 
middle of the spectrum was —2.0 ppm. 85% H3PO4 sealed in a capillary tube, which 
was placed in 90% H20 and 10% D20 was used as external standard. The spectra 
were processed using exponential multiplication (line broadening of 8.0 Hz). 
To investigate the binding of phosphate, apo-FBP (400 ,uM) was dissolved in 
physiological buffer (4 mM phosphate, 25 mM NaHCO3 and 100 mM NaCl, pH 7.4) 
and the protein solution was incubated at 310 K in a water bath for 12 hours and then 
a 31P spectrum was recorded at 310 K. To investigate the binding of phosphate to Hf-
FBP, a six-fold excess of Na2[Hf(NTA)21 solution was added to the apo-FBP 
solution and the mixture was incubated at 310 K for four hours, and then another 
spectrum was recorded at 310 K. 
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High Resolution Cation Exchange Chromatography 	Hf-FBP was prepared as 
described and then the buffer was changed to 10 mM Tris, pH 8.0. A cation 
exchange Mono STM HR 5/5 (Amersham) column was equilibrated with 10 mM Tris 
buffer (pH 8.0, buffer A). Protein samples were injected onto the column and eluted 
with a NaCl gradient from low to high salt concentration (0 - 200 mM) consisting of 
10 mM Tris, 200 mM NaCl (pH 8.0, buffer B). The experiments were performed on 
an AKTA Basic FPLC (Amersham), the elution rate was 0.5 ml/min and the eluant 
was monitored at 280 rim. 
Protein Crystallisation 	Crystals of Hf-FBP were grown by the hanging-drop 
method at 17 T. Purified Hf-FBP in 0.1 M KC1 was mixed with precipitant solution 
in a 1:1 ratio (v/v, 5 p1/5 Al). The precipitant solution was prepared from 20% PEG 
4000 (w/v), 0.4 M imidazole / malate buffer (pH 7.7) and 0.2 M KCI. 
4.3 Experimental Results 
4.3.1 Crystal Structure of Na2[Hf{N(CH2000)3}2]4H20 
The crystal structure is closely related to that of (NH4)2[Hf(NTA)2] published by 
Held et. al [22], but in this work, the tetrahydrate complex was prepared. The unit 
cell is different from the unit cell of the sodium salt prepared here 
The complex is a mononuclear eight co-ordinate complex. The structure is shown in 
Figure 4.1. The hafnium atom is surrounded by two nitrogen atoms and six 
carboxylate oxygen atoms. The hafnium atom is on a two-fold rotation axis and both 
co-ordinating NTA ligands are symmetrically equivalent with respect to this axis. 
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Figure 4.1 The X-ray crystal structure of the anion of Na2[Hf(NTA)2] 4H20 and 
atom numbering scheme. 
Table 4.2 Bond lengths for Na2{Hf{N(CH2COO)31214H20 

















Table 4.3 Possible hydrogen bonds (calculated by Platon® 2000) 
Type 	Donor- II ... Acceptor 	D-H (A) H ... A (A) D ... A (A) 	D-H ... A (°) 
Inter 	C(11)- H(11A).. 0(15) 	0.98 2.54 3.49 	161.73 
(D: Donor atom, A: Acceptor atom) 
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4.3.2 Characterisation of Hf(IV)-citrate Complex 
Following Dengel and Griffith's suggestion, the formula of the Hf(IV) citrate 
complex should be Na2[Hf(02)2(cit)]'H20 and it was only stable below pH 2. It was 
suggested that Hf(IV) is six-coordinate (assuming side-on co-ordination for 
peroxide) or seven coordinate if one molecule of water participates in the 
coordination sphere [21]. The complex was prepared with their method and 
characterized by JR with KBr slide and 'H NMR at pH 7. 
The JR spectrum of Na2[Hf(02)2(citrate)]H20 had a peak at 863cm' assignable to 
a peak at 646 cm-1 assignable to Vsym[Hf(02)],  and a peak at 520 cm 1 
assignable to Vasyrn[Hf(02)]. 
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Figure 4.2 'H NMR of Hf(IV)-citrate complex in D20, pH 7.0 at 25 °C. 
In the 'H NMR spectrum, there was a strong broad peak at Ca, 2.6 ppm, containing 
much fine structure, and a series of small peaks with fine structure between 3 and 4 
ppm. It seems likely that the Hf(IV)-citrate complex is oligomeric in water at pH 7.0. 
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4.3.3 Characterisation of Hf-FBP in Solution 
UV-Vis difference spectra The UV-Vis spectra of apo-FBP and Hf-FBP were 
recorded separately and the difference spectrum is shown in Figure 4.3. 
There is a strong peak at 247 nm and a broad peak was found at 294 nm in the LIV-
Vis difference spectrum. The absorption changes are due to the deprotonation of the 
tyrosine residues of FBP. Further reactions between Hf(IV) and apo-FBP was 
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Figure 4.3 The UV/Vis difference spectrum recorded by subtraction of spectrum of 
apo-Fbp for that of Hf-FBP in 10 mM Hepes buffer (pH 7.36), at 25°C. 
This reaction (Figure 4.4) took more than 20 h to reach the equilibrium under the 
above conditions. For transferrin, a synergistic anion is involved in metal binding. 
So, for FBP, the presence of anion may also be helpful for metal to be loaded to apo-
FBP. The synergistic anion found in the crystal structure of holo-Fbp is phosphate, 
and the synergistic anion of transferrin is carbonate, so these two anions might play 
an important role in the metal loading process. 
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Figure 4.4 Timecourse for reaction of Na2[Hf(NTA)2] with apo-Fbp in 10 mM 
Hepes buffer, pH 7.4, at 25°C, molar ratio 1:1(22.10 tM). 
In order to investigate the effects of anion in the metal loading process, further 
experiments were done in the presence of either carbonate or phosphate, at 25 °C and 
physiological pH. The reactions were monitored by UV-Vis at 245 nm (Figure 
4.5). 
The time course diagrams reveal that in the presence of bicarbonate or phosphate, the 
reaction was accelerated. At 25°C, in the presence of bicarbonate, the reaction was 
completed within Ca. 8 h, in the presence of phosphate, the reaction was completed in 
Ca. 15 h. Three peaks are present in the UV/Vis difference spectrum of each reaction 
system (-246 nm, -283 rim and -291 nm). 
Table 4.4 Time to reach equilibrium and extinction coefficient changes of three 
reaction conditions for the interaction between Na2[Hf(NTA)2] and apo-Fbp at 
25°C, pH 7.4. 
Buffer 	 Hepes 	Hepes and 	Hepes and 
bicarbonate 	phosphate 
As (M 1 cm') 	1 14128 	 13131 	 17061 
Time (h) 	 22 	 8 	 15 
ce 
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The reaction rate follows the order of Hepes and bicarbonate > Hepes and phosphate 
> Hepes only. The extinction coefficient change of the reaction in the phosphate 
containing system was greater than that of the reactions in the non-phosphate 
containing systems, this suggested that in the presence of phosphate, Hf(IV) can bind 
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Figure 4.5 Timecourse of reactions of Na2[Hf(NTA)2] (22 M) with apo-Fbp (molar 
ratio 1:1) in 10 m Hepes buffer in the presence of (A) bicarbonate (-22 M) or (B) 
phosphate ('-23 jiM), pH 7.4, at 25°C. 
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Although the reaction was significantly accelerated by bicarbonate or phosphate, it 
still took at least eight hours to reach equilibrium. Further studies were carried out to 
investigate the effect of: 1) changing the buffer; 2) increasing the reaction 
temperature to 37°C. 
First of all, the reaction temperature was maintained at 25°C, but the buffer was 
changed to physiological buffer (100 mM NaCl, 4 mM NaH2PO4 and 25 mM 
NaHCO3, pH 7.4), which contains a high excess of both phosphate and bicarbonate. 
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Figure 4.6 Timecourse for reaction of Na2[Hf(NTA)2] with apo-Fbp (22 M) in 
physiological buffer, 25°C, pH 7.4, Na2[Hf(NTA)2] / apoFbp = 2:1. 
The difference spectrum for this reaction was always the same as the difference 
spectrum of the reaction in Hepes or Hepes and bicarbonate. Three peaks were found 
at 318 rim, 245 rim. and 290 nm. 
Secondly, the buffer was Hepes only, without bicarbonate or phosphate, and the pH 
was kept at 7.4, but the reaction temperature was increased to 37 °C. The reaction 
was also accelerated, and reached equilibrium within 2.5 h (Figure 4.7). 
This experiment reveals that increasing the temperature accelerates the reaction. At 
25°C, it took Ca. 22 hours to complete the reaction, AE248 14000 M' cm'; whereas 
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at 37°C, the reaction was completed within 1.6 hours, /18248 26000 M' cm'. This 
suggested that at higher temperature, more tyrosine residues were deprotonated than 
at lower temperature. Two peaks were found from the difference spectrum, one was 
the strong sharp peak at 248 nm, and the other was a small broad peak at 298 mm 
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Figure 4.7 Timecourse curve for the reaction between Na2[Hf(NTA)2] and apo-Fbp 
(22 /LM) in 0.1 M Hepes buffer at 37°C, pH 7.4, Na2[Hf(NTA)2] / apo-Fbp = 2:1. 
Hence, to optimise the reaction conditions, the reaction was studied in the presence 
of both bicarbonate and phosphate and at 37°C. To investigate the influence of 
Hepes, the reaction was investigated in two systems: 1) Hepes, bicarbonate and 
phosphate (Figure 4.8), 2) NaCl, bicarbonate and phosphate (physiological buffer, 
Figure 4.9). 
These two experiments show that with the combined anions (bicarbonate and 
phosphate) and increased temperature, the reaction is completed very quickly. In the 
Hepes buffer, the reaction reached equilibrium in Ca. 45 minutes, 	34,000 M 1 
cm 1 , in the physiological buffer, the reaction reached equilibrium within 15 minutes, 
As 	10,500 M' cm-1 . The difference of /16 in two systems suggested that in Hepes 
buffer, Hf(IV) may bind more strongly to apo-FBP or more tyrosine residues were 
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Figure 4.8 Timecourse for the reaction of Na2[Hf(NTA)2] with apo-Fbp (22 AM). 
The buffer was 100 mM Hepes, 4 mM NaH2PO4 and 25 mM NaHCO3 at 37°C, pH 
7.4, Na2[Hf(NTA)2] / apo-Fbp = 2:1. 
Figure 4.9 Timecourse for the reaction of Na2[Hf(NTA)2} with apo-Fbp (22 jiM), 
Na2[Hf(NTA)2] / apo-Fbp = 2:1. The buffer was physiological buffer (100 mM 
NaCl, 4 mM NaH2PO4 and 25 mM NaHCO3) pH 7.4, at 37°C. The points are 
connected by straight lines without fitting. 
If Hf-citrate was used as starting material to react with apo-FBP, whatever the buffer, 
the reaction reached equilibrium within 20 minutes. 
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To determine the stoichiometry of Hf-FBP, apo-FBP was titrated with Hf(IV), and 
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Figure 4.10 Hf(IV) was loaded to apo-FBP by titration at stepwise Hf(IV) : apo-FBP 
molar ratios. The reaction was monitored at 247 rim in 10 mM Hepes, at 25 °C, pH 
7.4. Each sample was left 15 min to equilibrate before the absorbance was 
determined. Points were displayed without fitting. 
The titration experiment suggested that more than one Hf(IV) ions bind per apo-FBP 
molecule although only one ferric iron binds to FBP in wild-type holo-1713P. To 
confirm this result, Hf-FBP sample was analysed with ICP-AES. 
For 	all experiments below, Hf-FBP was prepared with Na2 [Hf(NTA)2] in 
physiological buffer. 
Quantitative elemental analysis by ICP-AES 	The hafnium, phosphorus and 
sulphur contents were determined at the same time. The result showed that the molar 
ratio of Hf: apo-FBP was 4.03 ± 0.10 and the molar ratio of P : apo-FBP was 1.39 ± 
0.04. 
31P NMR of Hf-FBP 	The result from ICP-AES analysis revealed that 
phosphate is involved in binding to Hf-FBP. From UV-Vis studies, it was known that 
both phosphate and carbonate play important role in Hf(IV) binding to apo-FBP. 
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Hence, 31P and 13C NMR were used to investigate the binding of phosphate and 
carbonate to Hf-FBP. 
Free phosphate 
Bound phosphate 
76543 ppm 7 6 5ppm 
Figure 4.11 31P NMR spectrum shows the binding of phosphate to Hf-Fbp prepared 
from physiological buffer. The left spectrum is the whole spectrum, the right one is 
the spectrum expanded to show the bound phosphate peak. 
The spectrum (Figure 4.11) showed that besides the free phosphate peak (3.28 ppm), 
new peaks were shifted downfield by 2-3 ppm. The main bound phosphate peak was 
found at 5.55 ppm, also, some smaller peaks were found around 6 ppm. This result 
provides evidence that phosphate can bind to hafnium in FBP. The multiple peaks 
mean that there are several phosphate binding environments in Hf-FBP. In the 13C 
NMR spectrum, besides the free bicarbonate peak, no bound bicarbonate peak was 
found. 
Characterisation of Hf-FBP by high resolution chromatography 	Purified 
Hf-FBP in 10 mM Tris (pH 8.0) was loaded into a cation exchange Mono STM HR 5/5 
(Amersham) column. The elution rate was 0.5 ml/min. The chromatogram is shown 
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different charges. This spectrum indicated that the Hf-FBP is heterogeneous in 
solution; there were at least five forms of Hf-FBP in the solution although under the 
same conditions, only a single peak was found for apo-FBP. 
Figure 4.12 Characterisation of Hf-FBP by chromatography on a MonoS1M HR 5/5 
(Amersharn) column. The left axis shows the absorbance of Hf-FBP at 280 nm, the 
right axis is the percentage of the buffer B (10 mM tris, 200 mM NaCl, pH 8.0). The 
grey line indicates the gradient of the buffer B applied during the elution process. 
The interaction between Hf(IV) and holo-Fbp was also studied by UV-Vis 
spectrometry. Hf(IV)-citrate complexes were incubated with holo-FBP in a 1:1 molar 
ratio, the reaction was monitored at 480 nm. 
The broad peak at 480 nm is the specific LMCT band of holo-Fbp. When holo-Fbp 
reacted with Hf(IV)-citrate, the decay of this peak means that Fe(III) was displaced 
from the specific ferric ion binding site (Figure 4.13). When the molar ratio between 
Hf and Fe was 1: 1, 47% of the bound Fe was replaced by hafnium (confirmed with 
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ICP-AES). Conversely, when Na3 [Fe(NTA)2J was mixed with Hf-FBP in a 1:1 molar 
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Figure 4.13 UV/Vis spectrum of holo-Fbp on reaction with Na2[Hf(NTA)2] in 
physiological buffer, pH 7.4 at 37 °C. The spectra were recorded at 5 minute time 
intervals. The band at 480 nm is the LMCT band of holo-Fbp. 
4.3.4 Crystal Structure of Hf-FBP 
The data for the crystal of Hf-FBP which contains 4.8 Hf(IV) per mole protein was 
collected by Dr. Dmitriy Alexeev (ICMB, University of Edinburgh) at 1.7 A 
resolution and the structure was solved by him by the molecular replacement phasing 
method. There are nine molecules (labelled A-I) in the asymmetric unit cell (space 
group P32). The crystal was twinned, but the structure was finally solved to 
Rcryst16.5 %  and Rfree 26.4%. 
The arrangement of nine molecules was complex. The whole unit cell and the stacks 
of nine protein molecules in the asymmetric unit cell are shown in Figure 4.14 and 
Figure 4.15. Nine protein molecules are labelled with A-I and individually coloured. 
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Figure 4.14 The complete unit cell. 
Space group P32, with the z-axis 
pointing towards the viewer. 
Figure 4.15 Stacks of molecules A-I 
in the asymmetric unit along the z-
axis. 
FBP has two hinged domains (a I P domains). In Figures 4.14 and 4.15, intersecting 
ellipsoids represent the two hinged domains of each protein molecule, the N-terminal 
domain is bigger. Small metallic balls in the middle indicate metal clusters. 
In Figure 4.15, different orientations of the stacks along the z-axis are indicated by 
the directions of arrows running through the hinge area of the protein molecule (up 
for A, B, C, G, H, down for 0, E, F, I). Molecules in each stacks of G, H and I 
molecules with the same colour are identical because they lie on a crystallographic 
three-fold screw axis (not shown). Both (A, B, C) and (F, 0, E) are made of similar, 
but not identical molecules, which are therefore differently coloured. Individual 
molecules in these stacks are related by approximate non-crystallographic three-fold 
screw symmetry and have slightly different conformations. The stack A, B and C 
(arrow up) and the stack F, D and E (arrow down) are anti-parallel. 
In holo-FBP, the hinge between domains is closed and only one Fe(III) is 
octahedrally coordinated to His9 and 01u57 from the N-terminal domain and di-
tyrosyl Tyrl95-Tyr196 from the hinge area, a water molecule and a phosphate as a 
synergistic anion bound to the C-terminal domain [23]. In apo-FBP the domain is 
open and mono-Fe(III) binding is accompanied by a hinge closure of approximately 
Chapter 4 Hafnium(IV)-FBP 
26° [24]. In Hf-FBP, Hf(IV) clusters bind to FBP in the metal-binding site. The 
interdomain hinge remains open and the side chains of His9 and G1u57, previously 
identified as Fe(III) ligands in closed mono-Fe-FBP, are swung away from the metal 
binding site. The hinge angles of nine molecules (A-I) in Hf-FBP crystal are various 
and on average only 5.5° smaller than that of apo-FBP. The hinge angle difference in 
the most closed molecule D and the most open molecule H is 8.4°. The group of 
three molecules G, H and I have a wider hinge angle than other molecules. 
The crystal environment of the metal-binding pocket among molecules is distinct, as 
the structures of the metal cluster at the metal binding site are different. Three main 
groups of hafnium clusters were found in the crystal, one is a trinuclear cluster with 
phosphate binding, and the others are pentanuclear clusters with and without 
phosphate binding. 
Figure 4.16 The positively charged molecular surface around the metal pocket 
(calculated by GRASP [25], as indicated in blue. 
Unexpectedly for cation binding, the surface of the Hf(IV) binding pocket is 
positively-charged (as shown in Figure 4.16). Besides bonded to the phenolate 
oxygens of Tyr195 and Tyr196, Hf(IV) ions are not contact with any of the protein 
atoms directly. Negatively-charged oxygen atoms bound Hf(IV) ions and bridge 
them in a manner similar to the structure of Hf02 [26] (Figure 4.19). 
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Figure 4.17 Lys and Arg residues in the vicinity of the Hf ions (gold spheres) in the 
cluster binding pocket. Bridging oxygens and the phosphate are omitted for clarity. 
ArgiOl is completely conserved in all FBP sequences. 
Tyr195 
Figure 4.18 Stereo view of SigmaA [27]-weighted (2F,-F,) electron density map for 
the smallest cluster (D) calculated with CNS [28]. The small unconnected red balls 
represent water molecules. The metal ions are coordinated to the protein through the 
phenolate oxygens of Tyr195 and Tyr 196. 
The molecule D represents the group with a trinuclear cluster. It is the most closed 
and contains the smallest cluster of only three well-ordered metals Hfl, Hf2 and HD 
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(Figure 4.18) in the crystal. Hfl is coordinated to Tyr196, Hf2 to Tyr195, and HO to 
Hfl and Hf2 through the bridging oxygens (Figure 4.19a). This trinuclear cluster is 
capped by a phosphate, which faces outward from the binding pocket. Each metal co-
ordinates to seven oxygens with pentagonal bipyramidal geometry. The five 
equatorial oxygens are oxides (or hydroxides), and the axial oxygens are from 
tyrosinate (or water for HO) and phosphate. The Hf"Hf distances range from 3.6 A 
to 3.8 A, and the Hf"O distances range from 1.9 A to 3.0 A with the Hf-tyrosinate 
bonds being the shortest. The Tyr195-Tyr196 OO distances of 4.03 A to 4.48 A are 
significantly longer than that in holo-FBP (3.01 A)[23], where both tyrosines are 
bound to a single Fe(III). The overall calculated charge on the first coordination shell 
is —7 (if all four bridging oxygens are oxide). The net positive surface charge on the 
metal-binding cleft (Figure 4.16) may facilitate formation of the protein-cluster 
complex. This assembly of trinuclear cores of Hf(IV) ions is common in inorganic 
complexes containing alkoxide, aryloxide, hydroxide and oxide ligands [29, 30]. 
Molecules A-F except molecule D contain pentanuclear clusters. Compared with the 
trinuclear clusters, the bound phosphate is replaced by an oxo-metal ion (Hf4, Figure 
4.19b). As in molecule D, Hfl, Hf2 and HO ions are fully ordered. The additional 
two ions Hf4 and Hf5 point into the solvent and are disordered. High electron density 
peaks (>10 a) and strong anomalous signals (>3 a) confirm that they are hafnium 
ions. The high temperature factors (B-factor = 95 A2) indicate that they are mobile. 
Hf5 forms an oxygen-bridged triangle with Hfl and Hf4, similar to the triangle Hfl - 
Hf2-Hf3 of cluster in molecule D but without central oxygen. Both Hf4 and HO are 
octahedrally coordinated to six oxygens. Molecules A-C have similar hinge angles 
and crystal contacts and contain similar metal clusters. The clusters in molecules E 
and F are different from the clusters in molecules A-C by an even higher 
mobility/disorder of Hf5. 
Clusters in molecules G-I are also pentanuclear clusters but with an additional 
phosphate (Figure 4.19c). Unlike the cluster in molecule D, the phosphate bridges 
Hfl to Hf4 and Hf5 in molecules G-I. In contrast to molecules A, B, C, E and F, Hf4 
and Hf5 in molecules G-I become well ordered (B-factor = 42 A2). The other pair of 
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Figure 4.19 Stereo views of Hf coordination in the protein nanoclusters and mineral 
Hf02. a, The smallest cluster in molecule D. Hf(IV) ions are gold and oxygen ions 
are red. Phosphate caps three Hf(IV) ions. b, The metal clusters in molecule A 
(clusters in B, C, E, F are similar). This cluster contains five Hf(IV) ions and no 
bound phosphate. c, Cluster in molecule G (clusters in H and I are similar). The Hfl, 
HA and HO ions are capped by phosphate. d, A fragment of the crystal structure of 
mineral Hf02 [26]. Molscript [31] was used to generate (a-d). 
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ions, Hf2 and HS, are well ordered in molecules A-F, and become mobile (B-factor 
= 92 A) in molecules G-I although Hf2 (bound to Tyr195) and HS are the most 
buried in the binding pocket. The phosphate capping the cluster Hfl -Hf4-Hf5 is 
identical to that of Hfl -Hf2-Hf3 in molecule D, but situated further away from the 
bottom of the metal binding pocket. 
Positional disorder seems to be associated with phosphate binding and not with the 
tyrosyl ligands. The size of the cluster correlates with the hinge-angle opening, the 
most closed molecule D contains the smallest cluster and the larger clusters are found 
in the more open molecules G-I. 
4.4 Discussion 
FBP is highly conserved among various pathogenic bacteria, so it is a potential target 
for broad-spectrum antibacterial drug design. Hetero-metal complexes can play the 
role of metalloantibiotics to inhibit the iron-uptake process which is essential for the 
survival of those pathogens. This targeting pathway could counter the rapidly 
growing problem of anti-microbial drug resistance. 
Experiments performed in this chapter reveal that Hf(IV) can bind to apo-FBP 
specifically. Whatever the starting Hf(IV) complex, Na2[Hf(NTA)2] or Hf-citrate, the 
UV-Vis difference spectra are the same. However, when Hf(IV) was loaded to apo-
FBP by Hf-citrate, the reaction reached equilibrium with 20 minutes in any buffer 
and at lower temperature (25 °C). When Na2{Hf(NTA)21 was used to load Hf(IV) to 
apo-FBP, the reaction rate was influenced dramatically by the components of buffer 
and temperature. The best loading conditions for Na2[Hf(NTA)2] were found at 37 
°C, in physiological buffer (100 mM NaCl, 4 mM phosphate, 25 mM bicarbonate, pH 
7.4), where the reaction can reach the equilibrium within 30 minutes. New bands 
appeared at 245 nm and 290 nm which are typical of phenolate groups (7r-7r 
transitions) generated by binding of Hf(IV) to Tyr 195 and Tyr196 in the iron-binding 
site of FBP. 
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The result from the titration experiment monitored by UV-Vis appeared to indicate 
that more than one Hf(IV) ions bind to FBP, but the ICP-AES result reveals that 
there are more than two hafnium ions bound to one protein molecule. The crystal 
structure gives a clear answer for this mismatch. There are two hafnium ions bound 
to Tyrl 95 and Tyrl 96 separately, which deprotonates the Tyr residues and causes the 
UV absorption change. Further hafnium ions form clusters via oxo bridges with 
hafnium ions bound to Tyr, and do not cause further deprotonation, so no further 
absorption change is monitored in this procedure. 
To determine which anion is involved in binding to Hf-FBP, 13C and 31P NMR was 
used. Hf-FBP was dissolved in physiological buffer, and 13C and 31P spectra were 
recorded. In the 13C spectrum, besides a free carbonate signal, no new peak appeared. 
However, in the 31P spectrum, new peaks, shifted downfield from free phosphate by 
2-3 ppm were observed. This evidence matches for phosphate binding agrees with 
the interpretation of the X-ray structure. The shape of the electron density of an anion 
in the crystal structure, which is tetrahedral, and the model of phosphate fits the 
electron density map very well, so the anion of Hf-FBP was determined as 
phosphate. Nevertheless, the crystal structure of Hf-FBP reveals that phosphate is not 
essential for Hf(IV) ions to bind to apo-FBP. Some molecules of Hf-FBP in the 
asymmetric unit cell has no phosphate binds to the Hf(IV)-FBP complex. 
Five peaks were found in the high-resolution ion-exchange chromatogram, which 
shows that there are multiple species of Hf-FBP present in solution. This is also 
found in the crystal structure of Hf-FBP, the nine molecules in the asymmetric unit 
cell can be classified in three groups, trinuclear clusters with phosphate bound, and 
pentanuclear clusters with and without phosphate. When ligands of Na2[Hf(NTA)2] 
were replaced by apo-FBP, without the protection of the chelating ligand and in the 
presence of water, hafnium forms various clusters in the metal-binding site of FBP. 
Open transferrin conformations are known with a single bound Fe(III) ion [32, 33, 
34]. Domain closure was not reported for mammalian transferrin treated with Hf-
NTA in solution [35]. When human apo-transferrin was treated with a 30-fold molar 
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excess of Na2[Hf(NTA)2] under similar condition as used for Hf-FBP preparations, it 
was found in the present work by ICP-AES that the Hf: protein: phosphate ratio was 
3.5:1:1.1, similar to FBP. This suggests that at least the N-lobe, which is wider open 
in the apo protein, binds Hf clusters. The cleft of the N-lobe of transferrin can open 
some 200  wider [36] than FBP and can contain more phosphate-binding sites [34], 
potential anchors for oxo-metal clusters. This, together with the high affinity of FBP 
for multimetal clusters, suggests that the N-lobe of transferrins could also bind metal 
clusters. The C-lobe may not be able to open wide enough to bind metal clusters, and 
this may be relevant to the functional difference between two lobes. 
It seems that cluster binding occurs as readily as mononuclear binding, which 
requires a conformational transition plus a synergistic anion (phosphate or 
carbonate). Helper anions are not necessary for cluster binding: oxygens of oxo 
clusters take the place of the synergistic anion in the positively-charged binding site. 
The metal binding cleft of Hf-FBP is open. 
Native holo-FBP contains a single metal ion anchored to two tyrosines in a closed 
inaccessible binding pocket and cannot take up further metal ions. The studying of 
Hf-FBP revealed that each tyrosine can bind to a separate metal ion. The two 
tyrosine residues bring these metal ions into close proximity, simulating further 
growth of cluster. Oxygens from the cluster replace the synergistic anion. Hence, the 
metal uptake pathway may also include bound multinuclear intermediates. 
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5.1 Introduction 
Vanadium has an atomic weight of 50.941 and its atomic number is 23. The 
electronic configuration is [Ar]3d34s2, and atomic radius (empirical) is 134 pm [1]. 
The discovery of vanadium is attributed to Andres Manuel del Rio (a Spanish 
mineralogist) who prepared a number of salts from a material contained in "brown 
lead" in Mexico City around 1803. Unfortunately, the French chemist Collett-
Desotils incorrectly declared that del Rio's new element was only impure chromium. 
Del Rio thought himself to be mistaken and withdrew his claim. The element was 
rediscovered in 1830 by the Swedish chemist Nils Gabriel Sefström who named it 
after the Norse goddess Vanadis, the goddess of beauty and fertility 
because of its beautiful multicolored compounds. It was isolated in nearly pure form 
by Roscoe, in 1867, who reduced the chloride with hydrogen. Vanadium of 99.3% to 
99.8% purity was not produced until 1922. Vanadium is found in about 65 different 
minerals among which are carnotite, roscoelite, vanadinite, and patronite, important 
sources of the metal. Vanadium is also found in phosphate rock and certain iron ores, 
and is present in some crude oils in the form of organic complexes. It is also found in 
small percentages in meteorites. Natural vanadium is a mixture of two isotopes, 50V 
(0.24%) and 51V (99.76%). 50V is slightly radioactive, having a half-life of> 3.9 x 
1017 years. Nine other unstable isotopes are recognised. Vanadium and most of its 
compounds are toxic and should be handled with care. The coordination chemistry of 
vanadium is summarised in Table 5.1. 
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V 1 , d6 6 Octahedral [V(CO)6], Li[V(bipy)3]4C4H80 
V°, d 5 6 Octahedral [V(CO)6], V(bipy)3, V[C2H4(PMe2)2]3 
V', d 4 6 Octahedral [V(bipy)3] 
Tetragonal pyramidal n 5-05H5V(CO)4 
7 Monocapped octahedral [V(CO)3(PMe3)4], V(CO)2(drnpe)2C1 
V", d3  4 Almost planar [Li(THF)]2V(2,6-diisopropylphenolate)4 
5 Square Pyramidal (216-Ph2C6H3O)2V(py)1  
6" Octahedra! [V(H20)6]2 , {V(CN)6]4 
V, d2 3 Planar V[N(SiMe3)2], V[CH(SiMe3)3]3 
4 Tetrahedral [VCI4] 
5 Trigonal bipyramidal trans-VCI3(SMe2)2, VCI3(NMe3)2 
6" Octahedral [V(NH3)6]3 , [V(C204)3]3 , VF1  
7 Pentagonal bipyramidal K4[V(CN)7]2H20 
VV, d' 4 Tetrahedral VCI4, V(NEt2)4, V(CH2SiMe3)4 
5 Tetragonal pyramidal VO(acac)2, PC14 VC15 
[VO(SCN)4]2 
Square pyramidal [V404(OH)2(PhPO3)4]2 
Trigonal bipyramidal VOCl2 trans-(NMe3)2 




6 Octahedral V02 (rutile), K2VC16, VO(acac)2(py), 
V(acac)2Cl2 
8 Dodecahedral [VCI4(diars)2], V(S2CMe)4 
Vv d° 	4 Tetrahedral (C3 ) VOCI3  
5 Trigonal bipyrarnidal V175 (g), VNCI2(quinuclidine)2 
Square pyramidal CsVOF4 
6(1 Octahedral VF5 (s), VF6 , V205 (very distorted, 
almost tbp with one distant 0); 
[V02(ox)2]3 , V2S5 
7 Pentagonal bipyrarnidal VO(NO1)3 CH3CN, VO(Et2NCS2)3 
'Most important states. 
5.1.1 The Chemistry of Vanadate in Water 
A summary of current understanding of the vanadate system in water is given in 
Figure 5.1. This shows how the existence of various vanadate species depends on the 
pH and on the total concentration of vanadium. In these equilibria, the site of 
protonation in the species [HVO4]2 , [H2VO41-, etc., is an oxygen atom (not 
vanadium); a more precise representation would therefore be [V03(OH)]2 , 
[V02(OH)21-, etc. However, the customary formulation is retained for convenience 
[3]. 
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Figure 5.1 Occurrence of various vanaUaLC and polyvanadate species as a function of 
pH and total concentration of vanadium [3]. 
It is evident from Figure 5.1 that only in very dilute solutions are monomeric 
vanadium ions found and any increase in concentration, particularly if the solution is 
acidic, leads to polymerisation [3]. 
5.1.2 Vanadium in Biological System 
The interest in vanadium chemistry from a biological and pharmacological 
perspective has exploded over the past 20 years, which is mainly based on the 
discoveries of the role of vanadium as an insulin mimic, and the presence of 
vanadium in certain haloperoxidases and nitrogenases [4, 5]. The chemical analogy 
between vanadates and phosphates is a key point for the understanding of how 
vanadium actually works in biological systems. One of the unclear questions is 
whether vanadate generally acts as a stable transition state analogue for phosphate 
blocking specific receptor sites or whether there are cases for which the vanadate 
substitution actually leads to new active sites with a completely different reactivity 
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with consequences for the pharmacological application and the toxicity of vanadium 
[6]. 
The particular importance of the biological function of vanadium is the ability of 
vanadium to influence phosphate-metabolising systems and the fact that vanadium is 
an inherent part of enzymatic active sites. For both types of vanadoenzymes known 
as vanadium-containing haloperoxidases and vanadium nitrogenases from the 
nitrogen fixing bacteria Azotobacter, functional analogs are found in nature which 
are either more widely spread or more efficient, e.g. the heme-containing haloper-
oxidases and the conventional nitrogenases with molybdenum cofactor, respectively. 
This leads to the question of how these enzyme systems evolved and in particular 
whether the vanadium-containing enzymes known today are retained functional 
analogs, which simply could sustain evolutionary forces [6]. New insight concerning 
these questions may be gained on the basis of newly found similarities for vanadate 
and phosphate in biological systems [7]. 
The wide-spread physiological effects of vanadium are mainly attributed to the 
similarity between vanadate(V) and phosphate. But there are also important 
differences between these two anions. At physiological pH values, monovanadate is 
found as doubly-protonated [V02(OH)2] species, whereas phosphate occurs in the 
monoprotonated form HP042 . This is also important for possible mechanisms of the 
transport systems for these two anions [8, 9, 10]. In addition, vanadium is easily 
reduced under physiological conditions to yield cationic species [V(V)/V(IV), E° = 
1.00 V, V(IV)/V(III), E° = 0.34 V, V(III)/V(II), E° = - 0.26 V]. The third difference 
is given by the pronounced ability of vanadium to adopt higher coordination 
numbers. The higher coordinative flexibility of vanadium can deliberately be used 
for the structural characterisation of phosphate metabolising enzymes [6]. 
Recently the crystal structures of several stable enzyme aggregates of phosphatases 
with vanadate as a transition state analogue have been reported. Interesting examples 
are the protein tyrosine phosphatases [11, 12], which are involved in signal 
transduction mechanisms for controlling and regulating intracellular processes (e.g. 
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the insulin receptor system). In these aggregates, the vanadium is trigonal 
bipyramidal and linked to the protein with a single axial bound cysteine residue, 
whereas the oxygen atoms of the vanadate moiety are involved in a hydrogen 
bonding network. A similar structure is found for the active site of rat prostatic acid 
phosphatase with the complexed transition state analogue vanadate [13]. 
It is said that vanadate complexes show insulin-mimetic effects [14]. The first 
chelated vanadium complex designed and tested chronically in vivo as an insulin 
mimetic agent (bis(maltolato)oxovanadium(IV), BMOV) has been thoroughly 
characterized chemically [15, 16] and tested biologically [17, 18]. 
Figure 5.2 Crystal structure of bis(maltolato)oxovanadium(IV), (BMOV) [15]. 
frr






Figure 5.3 The metal binding site of rat prostatic acid phosphatase with the transition 
state analogue vanadate complex [13]. 
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The overall structure of the enzyme remains unchanged upon binding of the metal 
oxyanions, only local conformational differences in the positions of some side chains 
at the active site were found. The vanadium is linked to the protein through an 
axially bound histidine residue, and forms a trigonal bipyramidal coordination 
geometry. The metal ion is within coordination distance of the His 12 side chain 
which is located at one of the axial positions. The three equatorial oxygen atoms 
interact with the conserved residues ArgI 1, Argl5, Arg79 and His257. Within 
hydrogen-bonding distance of the axial oxygen atom is the side-chain of the 
conserved residue Asp258 [13]. 
It has been found that vanadium can bind to transferrin in blood [19, 20, 21]. Some 
research in vivo showed that in serum, vanadium is mainly bound to transferrin; 
however, a small amount of vanadium is also bound to albumin. Besides these two 
V-protein complexes, a significant part of vanadium occurred as readily 
exchangeable ("free") vanadium [22]. In vitro, vanadate binds to the metal-ion 
binding site in transferrin in the absence of anion as the dioxovanadium(V) cation, 
VO [23]. It has been suggested that the ligands normally provided by the anion are 
supplied by the two oxo ligands of dioxovanadium. Thus V02 is believed to be 
coordinated in a trigonal bipyramidal or octahedral fashion to two tyrosines, an 
aspartate, as well as hydrogen bonded to a histidine and an arginine through the oxo 
group [24]. The study of possible relationships between iron and vanadium 
metabolism has been extended to the vanadium in the biochemical mechanisms 
which involve the exchange of iron between transferrin and ferritin. The results show 
that the maximum transfer was observed when V-transferrin and V-ferritin were 
mixed in their natural environments, such as plasma and liver cytosol, but no transfer 
of vanadium between two proteins was observed when the two proteins were mixed 
and incubated in a buffer at physiological pH. This suggests that the exchange of the 
vanadium between the two proteins is affected by biochemical factors which are 
present in the body [25]. 
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5.1.3 Summary of Study in this Chapter 
In order to investigate the binding of vanadate to the FBP. 51V quadrupolar central 
transition (QCT) NMR, 31P NMR and X-ray crystallography were used. (I) From 5  1 V 
NMR, information about the symmetry and motion of the bound metal ion was 
obtained from the chemical shift of 51V. The effects of pH, ionic strength, solvent 
and temperature on the chemical shift of 51V were also examined. (2) The phosphate 
vanadate analogy was investigated by the replacement of bound phosphate in holo-
FBP by vanadate, and 31P NMR was used to monitor the replaced phosphate. (3) The 
detail of vanadate binding to apo-FBP was studied by X-ray crystallography. 
5.2 Experimental Methods 
5.2.1 51V Quadrupolar Central Transition (QCT) NMR 
Several properties of the 51V nucleus make it ideal for studies of the protein-bound 
metal ion [26, 27]. 51V is a quadrupolar nucleus (I = 7/2) with a high natural 
abundance (99.75%) [28], and very good NMR sensitivity (six times more sensitive 
than 31P). The interaction of the nuclear quadrupole moment with the electric-field 
gradient at the vanadium nucleus allows for the determination of second-order 
quadrupole effects that can be used to characterise the symmetry of the local 
environment [29]. Spectra generated from a quadrupolar nucleus bound to a protein 
therefore can provide information on the symmetry of the ligand environment around 
the nucleus as well as its motion. This approach has been used successfully with the 
transferrins using 51V NMR [30, 31, 321. In addition, the nuclear quadrupole moment 
of 51V is very small (-0.052i0 28 m2) [30], thus it can potentially give well resolved 
spectra. The chemical shift range of 51V is vast (> 4000 ppm) [30], and reflects its 
sensitivity to the coordinated ligands and local environment [24, 33]. 
The dominant relaxation mechanism for a half integer quadrupolar nucleus (nuclear 
spin, I > ½) is quadrupolar relaxation. This relaxation mechanism has features that 
are ideal for the study of macromolecules by NMR. The detection of higher 
resonance frequency half-integer quadrupolar nuclei in the limit of slow molecular 
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motion can reveal information about the motion of the metal ion as well as the 
symmetry of its local environment through second-order quadrupole interaction [34]. 
Different from spin = 1/2 nuclei, the line-width of the resonance of a half integer 
quadrupolar nucleus decreases as both molecular weight and magnetic field strength 
increase when wore >> 1 (w0, Larmor frequency; r, rotational correlation time), due 
to the detection of only the central quadrupolar transition [30]. 
Details of quadrupolar relaxation theory can be found in various references [35, 36, 
37]. Several equations have been derived to describe the properties relevant to the 
work in this Chapter. Information about the metal binding site of FBP is directly 
obtained from the chemical shift (ôobs) and the line-width (Av172) of a bound nucleus. 
These two properties of the central transition (m1 = V2  - m1 = - ¼) reflect changes in 
the quadrupole coupling constant (, deviation from the isotropic chemical shift (ô), 
and 	of the bound metal ion. In the condition of slow isotropic molecular motion 
(wore >> 1), also called "far from extreme narrowing," the line width of the central 
transition of a I = 7/2 nucleus (51V) is given by [37]: 
AVII2 2.5.10—f— 
Vo 
X (quadrupole coupling constant) is a measure of the coupling between the electric-
field gradient and the nuclear quadrupole moment at the nucleus [38]. Thus, as the 
symmetry of the ligand field around the nucleus increases, x and Av112 decrease, so 
this can be used as a measure of local environment around the atom of interest. Line-
width is also inversely proportional to the resonance frequency of the nucleus (p0) 
and its rotational correlation time. This is opposite to what is observed for spin = V2 
nuclei because as the above equation implies, slowing the motion of the metal ion, 
either by decreasing the temperature or increasing the size of the macromolecule to 
which it is bound, decrease the line-width of the NMR signal. The correlation times 
of the various transferrins and their half molecules [39] are of suitable magnitude to 
allow the detection of QCT NMR signals from various quadrupolar nuclei bound in 
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the metal-ion sites. Furthermore, by using high-field NMR spectrometers, the spectra 
of quadrupolar nuclei can be vastly improved through the narrowing of line-widths. 
The observed chemical shift (sobs)  of a quadrupolar nucleus experiencing slow 
isotropic motion can also be used to assess the symmetry of the local environment of 
the nucleus due to a "second order dynamic frequency effect" [37, 40] which causes 
an upfield shift of the central transition and is dependent on the external magnetic 
field. As derived elsewhere [41, 42], this shift can be described for a I = 7/2 nucleus: 
A81 = 6o1,s 	= — 2.510 
VO 
where 6i is the isotropic chemical shift. If B0 is increased, the second-order effect 
decreases, causing the observed signals to shift downfield toward the isotropic value. 
This second-order effect allows the calculation of x simply by obtaining chemical 
shifts at different magnetic field strengths [43]. 
5.2.2 Sample Preparation and 5 'V NMR of V-FBP 
Vanadium-FBP samples for NMR spectroscopy were prepared by dissolving 
lyophilised apo-.FBP in 6 ml 10 mM Tris, (H20/D20, 90%/10%, v/v), then 50 1d of 
saturated (20 °C) aqueous NH4VO3 (Aldrich, Cat. No. 20,555-9)) (H20/D20, 
90%/10%, v/v) was added to the protein solution; the final pH was 7.8. The mixture 
was incubated in 37 °C on a water bath for 6 hours before the NMR spectra were 
recorded. The final concentration of the protein was 436 tiM. The vanadium-holo-
FBP complex was prepared as described in section 5.2.3. All 51V NMR spectrum 
were recorded on a Bruker DMX 500 ('yo = 131.5 MHz) spectrometer fitted with a 5 
mm BBO probe at 37 °C. VOC13 [vanadium(V) oxytrichioride, Aldrich, Cat. No. 
20,089-1] was used as external shift reference; it was sealed in a capillary tube under 
argon atmosphere, and then this capillary tube was put inside a sealed 5 mm NMR 
tube containing D20. V-FBP spectra were acquired with a pulse length of 27.75 its at 
9 dB (90°). The relaxation delay was 3 seconds, and the frequency width was 66 
kHz. The number of scans was 15872. The time domain size was 16 k and data were 
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processed with an exponential function, resulting in a line broadening of 20 Hz. 
Saturated NH4VO3 solutions ( 50 mM) were prepared under various conditions to 
study the effects of solvent, temperature, buffer, ionic strength, and pH on the 
chemical shift of 51V. The samples were prepared in D20, 10 mM Hepes (D20, pD 
7.4, pD = pH*+0.4), (90% H20, 10% D20), (90% H20, 10% D20 with 0.1 M KC1) 
and in (90% H20, 10% D20 with 0.1 M KC1 at pH 7-10). The pulse length was 27.75 
As at 9 dB (90°), relaxation delay 3 seconds, and frequency width was 66 kHz. The 
number of scans was 128. The time domain size was 16 k. 
5.2.3 ICP-AES Analysis of V-FBP 
V-FBP was purified on a cation exchange M0n0STM  column eluted with 10 mM Tris, 
pH 8.0. The standard atomic absorption solution (Aldrich) was diluted with 10 mM 
Tris buffer (pH 8.0). The analysis was performed on a Thermo Jarrell Ash IRIS 
instrument. Total protein concentration was determined from the S concentration (1 
S per mol protein; Met 308) without digestion. Values are averages of three 
determinations of the sample. The concentration of sulphur was determined from the 
emission at 182.034(142) rim, and the concentration of vanadium from the emission 
of 309.311(84) nrn. 
5.2.4 3 'P NMR Studying of Vanadate Displace Phosphate from ho/o-FBP 
31P NMR spectra were recorded at 202.4 MHz at 310 K on a Bruker DMX 500 
spectrometer using a 5 mm BBO probe. An aliquot of a saturated NH4VO3 solution 
(100 1.d) was added to 500 l of holo-FBP solution (920 /.LM, in 10 mM Tris, 50 mM 
NaCl, pH 8.0), and the mixture was incubated at 37 °C for 102 hours, then 70 Al D20 
was added to the protein solution to provide an NMR lock. The spectrum was 
collected using a pulse width of 22.65 its at 9.00 dB, relaxation delay 2 s, 8192 data 
points and 14336 transients. The spectral width was 30 ppm and the middle of the 
spectrum was set as 0.0 ppm. A sealed capillary containing 85% H3PO4 was used as 
external standard. The spectra were processed using exponential functions (line-
broading of 20 Hz). 
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5.2.5 Preparation of V-FBP 
Vanadium(V)-FBP was prepared by mixing the freshly prepared saturated NH4VO3 
solution with apo-FBP solution in 10 mM Tris buffer, pH 8.0 and incubated in 37 °C 
water bath for 3 hours. The product was initially purified using a PD-10 column, 
followed by ultrafiltration (AmiconTM YM-30, Millipore) with 10 mM Tris, pH 8.0. 
5.2.6 Crystallisation of V-FBP 
V-FBP was crystallised using the hanging drop method. Large needle crystals 
appeared in the drop composed of 21% PEG 4000, 0.5 M imidazole buffer (pH 6.4) 
within two weeks. However, the unit cell of this form of crystal is large (25 
molecules per unit cell), so the resolution was not good (-3.5A). 
Better V-FBP crystals were prepared by soaking. High quality apo-FBP crystals 
harvested from a drop composed of 31% PEG 1450, 0.4 M imidazole buffer, (pH 
7.2) were soaked in an NH4VO3-containing solution for more than 12 hours at 17 °C. 
The soaking solution was prepared by mixing 20% stock solution and 80% well 
solution (31% PEG 1450, 0.4 M imidazole buffer, pH 7.2). The stock solution was 
prepared with 30% PEG 1450, 0.4 M imidazole buffer, pH 7.2 and saturated with 
NH4VO3. 
5.3 Experimental Results 
5.3.1 Factors that Influence the Chemical Shift of 51V 
As shown in Figure 5.1, the chemistry of vanadium in aqueous solution is very 
complex. A large variety of species can form depending on the pH, ionic strength, 
and concentration [44]. Previous studies have shown that vanadate can react with 
various buffers [331, and pH has a marked effect on the spectra of aqueous 
vanadium. Here, the effects of solvent, ionic strength, temperature, and buffer on the 
chemical shift of 51 V were examined at neutral pH. Also, the effect of pH on the 
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-560 -580 -600 ppm 	
-500 -550 -600 :ppm 
Figure 5.4 (a) 51V NMR spectrum of saturated aqueous NI-LV03 (50 MM). (b) 51V 
NMR spectrum of 0.4mM NH4VO3 in 90% H20, 10% D20, 10 mM Tris, p1-I 8.0. 
I 	 I 	 I 	 I 
-540 -560 -580 	ppm 
Figure 5.5 p1-I effects on 51V chemical shift. The sample is a saturated aqueous 
NH4V03 solution. 51V spectra were recorded at pH 7.23 (black line), pH 8.02 (red 
line), pH 9.00 (green line) and pH 10 (blue line). Main peaks of red line, green line 
and black line at -577 ppm were perfectly overlaid. 
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90% H20 and 10% D70 25°C 
90% F120 and 10% D20, 
0.1 MKCI 	 100% D20, 25 °C 
90%H2Oand 10%D2037°C 
—560 —570 —580 —590 ppm 
Figure 5.6 Solvent, temperature and ionic strength effects on 51V chemical shift. The 
sample was saturated aqueous NH4VO3 solutions (50 mM). The pink line and the 
blue line are perfectly overlaid. 
All peaks in Figure 5.4 - Figure 5.6 were assigned according to references 30, 31, 
32. VOC13 was used as external standard (0 ppm). 
51V NMR spectra shown in Figure 5.4 reveal that different species exist in saturated 
aqueous NH4VO3 solutions (50 mM) and diluted NH4V03 solution (0.4 mM). 
Figure 5.4a shows that the main species in the saturated N144V03 solution (50 mM) 
is V401241V3093 (a sharp single peak at about -578 ppm). However, as shown in 
Figure 5.4b, when the sample was diluted from -50 mM to 0.4 mM, and the spectra 
were recorded at the same solvent, buffer, pH as the saturated sample, a new peak 
appeared, which was assigned to HV0421H2VO4 (-557.8 ppm). Two sharp peaks at 
-571.9 ppm and -576.8 ppm were assigned to V401241V3093 . The results revealed 
that a mononuclear vanadate species was formed when the sample was diluted. The 
concentration of vanadate in the sample used to record the spectrum in Figure 5.4b 
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was almost the same as in the V-FBP sample used to record the 51V NMR spectrum, 
so the spectrum in Figure 5.4b can be used to be a reference spectrum for the 51V 
spectrum of V-FBP. 
Figure 5.5 shows the effect of pH on chemical shift of 51V. The results show that 
between pH 7 and pH 9, the peak for the main species was stable (fully overlapped, 
black line, pH 7.23, red line, pH 8.02, green line, pH 9.00). However, when the pH 
was increased to 10 (blue line), the peak was shifted downfield by 39.1 ppm. For the 
51V NMR experiments performed in this Chapter, the pH range of the reference 
sample (0.4 mM aqueous NH4VO3) and the V-FBP is between pH 7 and pH 8, hence, 
there is no pH effect on the chemical shift difference between the two samples. 
The effects of solvent, temperature and ionic strength on the chemical shift of 51V 
were investigated by 51V NMR and the spectra are shown in Figure 5.6. The results 
show that when the solvent is changed from 100% D20 (brown line) to 90% H20 and 
10% D20 (red line), the main peak shifted to downfield by 0.6 ppm. In the same 
solvent, when the temperature was changed from 25 °C (red line) to 37 °C (blue line), 
the main peak shifted downfield by 0.8 ppm. At the same temperature, when 0.1 M 
KC1 was added (pink line), there was no change in the NMR spectra at all. So, 51V 
NMR experiments for both reference sample and V-FBP sample were performed in 
the same solvent and the same temperature. 
5.3.2 Vanadium(V) Binds to apo-FBP and holo-FBP 
There is no previous report of the binding of vanadate to FBP, although it has been 
reported that vanadate can bind to transferrin [21]. Here, the binding of vanadate to 
apo-FBP was investigated by 51  V NMR, which shows that vanadate does bind. 
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-500 	-550 	-600 	ppm 
Figure 5.7 51V spectrum of V-FBP (436 tiM) with excess vanadate (V / protein = 
10:1) at 37°C, in 10 m Tris, pH 8.0. 
Compared with the reference spectrum shown in Figure 5.4b, new peaks appeared at 
-543.8 ppm (peak 1), and there is a broad peak (peak 5, -582 ppm) overlapping with 
peak 3 and 4. According to the chemical shift of free species in literatures [30], and 
the chemical shift of bound vanadate in transferrin [30], peak 1 is assigned to the 
species V02 bound to the protein. The broad peak (peak 5) overlapped with peaks 3 
and 4 is assigned to V401247V3093 species, the broadening of the peak is due to 
binding to the protein. However, when excess vanadate in the protein solution was 
removed with gel-filtration chromatography, the ICP-AES analytical result of this 
purified sample shows that the V/protein ratio is 0.99 ± 0.2. 
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-500 	 -550 	-600 	ppm 
Figure 5.8 5 1  V NMR spectrum of ammonium vanadate (V/protein = 10:1) in 11 mM 
Tris, 100 mM NaCl, incubated with holo-FBP (690 tiM) 
Figure 5.7 is the spectrum of apo-FBP incubated with excess of vanadate, Figure 
5.8 is the spectrum of holo-FBP incubated with a 11-fold molar excess of vanadate. 
Comparing the two spectra, it is evident that the peak at -543.8 ppm in Figure 5.7 
has disappeared in Figure 5.8. This reveals that in the holo-FBP sample, vanadate 
cannot displace Fe(III) from the metal binding site; this is also confirmed by the 
presence of the red colour of the holo-FBP sample, which means that Fe(III) is still 
bound to the protein. In both spectra, in addition to the sharp peak at -558 ppm of 
free vanadate, the peaks at around -580 ppm are broad, which means that vanadate 
species V401247V3093 interact with the protein. Nevertheless, bonds between V02 
and V401247V3093 and the protein might be weak. This is the reason why V40124 
are lost during the purification of V-FBP by chromatography and the ICP-
AES analytical result showed that only one vanadium atom is bound strongly to one 
protein molecule. 
One of the most important biological properties of vanadium is its analogy to 
phosphate. 51V NMR proved that vanadate can interact with holo-FBP without the 
replacement of the ferric ion; then the question is what is the nature of the interaction 
site between vanadate and holo-FBP? Can vanadate play the same role as phosphate 
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in holo-FBP? To find the answer of this question, 31P NMR was used to investigate 
whether vanadate can replace phosphate from holo-FBP. 
6 4 2 0 ppm 
Figure 5.9 31P NMR spectrum of holo-FBP (690 M) containing an 11-fold molar 
excess of vanadate in 10 mM Tris, 100 mM NaCl. The sample is the same as used to 
record the spectrum in Figure 5.8. 
A 31P NMR spectrum of holo-FBP was recorded, and no phosphate signal was found 
due to the paramagnetic effect of Fe(III). However, after the addition of an 11-fold 
molar excess of vanadate, a phosphate peak appeared at 2.9 ppm, which was 
assigned to free phosphate. This shows that vanadate can displace phosphate in holo-
FBP; This result suggests that in V-FBP, in the presence of excess vanadate, 
vanadate clusters (V401247V3093 , as shown in Figure 5.7) can bind to V02 in the 
role of an anion. 
5.3.3 Crystallisation of V-FBP 
Crystal of V-FBP were prepared by soaking apo-FBP crystals in a vanadate-
containing soaking solution. Diffraction data were collected using a rotating anode 
generator RF591 (X = 1.488 A) by Dr. Dmitriy Alexeev (ICMB, University of 
Edinburgh). 
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Table 5.2 Crystallographic Data for Vanadium(V)-FBP 
Wavelength 	 1.542 A 
Resolution 	 2.00 A 
Crystal System 	 Hexagonal 
Space Group 	 P32 
Unit Cell Parameter 	 a = b = 146.93 A, c = 114.70 A 
a=fl=90°y= 120° 
Refl. Collected/Unique 	2102722/346722 
Molecules/Asymmetric Unit 9 
Temperature (K) 	 100 
Completeness (%) 	 98.3% 




The structure determination work for V-FBP by Dr. Dmitriy Alexeev is still in 
progress. The initial results show that the V-FBP crystal has the same space group as 
the other FBP crystals. The crystal structure of V-FBP will hopefully give a clear 
view of the coordination geometry of V-FBP in the metal binding site of FBP. 
5.4 Discussion 
V-FBP is the first observation of vanadium bound to bacterial transferrin. 
Experiments performed in this Chapter suggest that vanadate can bind to apo-FBP 
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strongly as the species V02 . In the presence of excess vanadate, vanadate clusters 
V40124 /V3093 can also interact with the protein. However, the interaction between 
the vanadate cluster and protein is weak, and the vanadate cluster was readily lost 
during the purification procedure with gel-filtration chromatography. 
In addition, vanadate can also react with holo-FBP, and the anion of holo-FBP 
(phosphate) can be replaced by vanadate in the presence of an 11-fold molar excess 
of vanadate, but the bound Fe(III) cannot be replaced by vanadate. This discovery 
matches the performance of vanadium in vitro studying - its analogy to phosphate. 
These results suggest that in the presence of excess vanadate, vanadate clusters 
V4012 4_/V3 093- may play the role of anion in the protein and interact with holo-FBP 
at the position of phosphate. As has been discovered in previous Chapters, vanadate 
clusters V401247V3093 may form weak bonds with FBP-bound vanadium ion via 
oxygen bridges to form a bigger cluster. 
The high-quality V-FBP crystal diffracts to 2.0 A resolution. This provides a chance 
to clarify all the assumptions of the bonding and geometry situation in the metal 
binding site of V-FBP with further structural determination work. 
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Chapter 6 Conclusions and Future Work 
6.1 Conclusions 
FBP is a convergent nodal point for Fe(III) trafficking subsequent to a variety of very 
different transport strategies across the outer membrane. It belongs to the transferrin 
superfamily, which encompasses the mammalian transferrin proteins. Transferrins 
and FBP are structurally and functionally related [1]. 
All previous studies have shown that FBP is a mono-iron complex, and it was 
assumed that iron is transported across the periplasm only as mononuclear centres. 
The Fe3-FBP characterised in this work (Chapter 3) appears to be the first example of 
an oxo tn-iron centre in a metalloprotein. It is well known that (hydr)oxo-di-iron 
centres are present in ribonucleotide reductase, methane monooxidase, and 
hemerythyrin [2]. Ferritin has a particulate core of Fe(0)OH, taken up as Fe(II) and 
oxidised in gated pores in the protein coat [3, 4]. Sulfide-bridged di, tn- and tetra-
iron clusters are found in ferredoxins. Ferredoxins have a multitude of diverse roles 
including electron transport, and probably sustained early life in a highly reducing 
environment. [5]. The finding that FBP can bind oxo-iron cluster adducts suggests 
the possibility that small fragments of (hydr)oxo iron minerals could be involved in 
iron trafficking. It is known that FBP has access to the outer surface of the bacteria 
[6], so clusters might be acquired directly from the external environment by 
periplasmic FBP or might be assembled from uptake of mononuclear iron (Figure 
6.1). A database search revealed that nearly half of the bacteria which possess a FBP 
homolog also possess a FecA homolog (Appendix 1). FecA might therefore be 
considered as a possible donor of polynuclear iron to FBP. 
In the structure of mono Fe-NTA-FBP (Figure 3.14), Fe(III) is shielded from solvent 
by the chelated NTA ligand in much the same way as by bound EDTA in the 
recently reported structure of Haemophilus influenzae Fe-EDTA-FBP in which His9 
had been mutated to Gln [7]. The authors concluded that the open cleft conformation 
was trapped by crystal packing forces, but the Fe-NTA-FBP was crystallised from 
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formed complex, thus, the cleft opening observed does not appear to depend on such 
packing forces. 
Figure 6.1 Stylized view of iron acquisition pathways for Gram-negative bacteria. 
Shown across the top of the bacterium are outer membrane (OM) receptor-mediated 
uptake of iron from Fe3 —siderophores by FhuA, FepA, FecA or any of numerous 
other siderophore receptors; hemin or hemoglobin by HmbR or HpuR or other heme 
. 	3+ receptors; and Fe 3+  —transfernn or Fe —lactofernn by TbpA or LbpA, respectively. 
Cell-surface reductases can also be present that facilicate iron transport across the 
outer membrane (not shown). In some cases TonB or ABC transporters, which 
transport the iron across the cytoplasmic membrane (CM), are coupled with the OM-
receptor transport processes. Fbp also facilitates transport of iron across the 
periplasmic space to the CM. Along the bottom of the bacterium, the question of 
whether Fbp can sample the outer bacterial surface is raised. Can Fbp come in 
contact with oxophilic metal—containing minerals to sequester Fe 3+  and other metal 
ions? [1] 
As shown by the structures of Fe3-FBP and apo-FBP (Figure 3.15 and Figure 3.13), 
the mobility and acid-base properties of the side-chains provide the dityrosyl motif of 
FBP with a potentially versatile role in the capture and release of iron. Although in 
most of the protein molecules in the unit cell of Fe3-FBP the tn-iron cluster is 
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anchored by Tyr196 as a triply-bridging ligand and by Tyr195 as a monodentate 
terminal ligand, either Tyr residue can also act as a single arm anchor for the cluster. 
Hence, the versatile structural roles of these Tyr residues may provide facile 
mechanisms for iron uptake and release either as mono- or polynuclear centres. A 
potential role for Tyr196 is to guide iron complexes into the cleft. Evidently the two 
iron-binding tyrosine residues can have distinctly different roles within the binding 
cleft of FBP as has been illustrated for human transferrin by mutation of Y95 and 
Y188, the metal-binding tyrosines in the N-lobe cleft [8], and for the duck NIT 
domain fragment [9]. 
Fe(III) in open-cleft FBP is accessible and potentially reactive. The phosphatase 
activity observed (Section 3.3.6) provides a mechanism for signalling iron status by 
coupling cluster breakdown and cleft-closure around a single iron. This might also be 
an alternative way for bacteria to obtain phosphate in the phosphate poor 
environment. 
The crystal structure of hafnium-FBP (Section 4.3.4) gives a good example of 
hetero-metal FBP interaction. Hafnium can bind to apo-FBP as oxo-hafnium clusters 
with 3 - 5 hafnium ions. This suggests that the metal binding cleft of FBP can 
accommodate large clusters, which means larger iron mineral fragment could be 
formed in the metal binding motif. Phosphate is important but it is not essential for 
the hafnium loading process. 
Vanadium showed dual roles in FBP. Vanadate can bind to apo-FBP, and clusters 
were also formed in the metal binding site in the presence of excess of vanadium. In 
addition, vanadate can take the place of phosphate in holo-FBP, which shows its 
property as a phosphate mimic in FBP. The crystals of V-FBP which I prepared will, 
it is hoped, eventually yield the structural details of V-FBP at atomic resolution. 
It has been found that transferrin can bind to more than 30 metals [10]. Previous 
studies show that both hafnium and vanadium can bind to the N- or C- lobes of 
transferrin as single ions [11, 12]. In these studies of Hf-FBP and V-FBP, it is found 
that they are quite similar to Fe-FBP; both metals can form clusters in the metal 
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Appendix I 
Sequence (in bold) and secondary structure of holo-FBP from Neisseria gonorrhoeae 
(PDB code ld9y, McRee etal, unpublished). Secondary structure is calculated and 
described according to the method of Kabsch and Sander, Biopolymers 22, 2577-
2637 (1983). The assignments are: H=helix; B=residue in isolated beta bridge; 
E=extended beta strand; G=310 helix; I=pi helix; T=hydrogen bond turn; S=bend. 
Chain ID9Y:A 
Compound Periplasmic Iron-Binding Protein 
Type Protein 
Molecular Weight 33641 
Number of Residues 309 
Number of Alpha 12 	Content of Alpha 	40.13 
Number of Beta 11 Content of Beta 17.15 
(A) Amino acid sequence of N gonorrhoeae Fbp and conserved residues in homologs. 
Sequence with grey highlights for residues conserved in organisms listed in (B), 
sequence with underline highlighs for residues bound to Fe(III) in holo-FBP. 
(A) Sequence and secondary structure 
1 DITVYNGQHK EA1QAVADAF TRATGIKVKL NCAKGDQLAG QIKEEGSRSP 
EEEEE S H HHHHHHHHHH HHHH EEE EES HHHHHH HHHHHGGG 
51 ADVFYSEQIP ALATLSAANL LEPLPASTIN ETRGKGVPVA AKKDWVALSG 
SEEEESSHH HHHHHHHTT B 	TTTHH HH TT 	TTS EE EE 
101 RSRV\TVYDTR KLSEKDLEKS VLN(ATPKWK NRIGYVPTSG AFLEQIVAIV 
EEEEEEEETT T GGGS SS GGGGTTGGGT TTEEEETT H HHHHHHHHHH 
151 KLKGEAA.ALK WLKGLKEYGK PYAXNSVALQ AVENGEIDAA LINNYYWHAF 
HHHTHHHHHH HHHHHHHHSE EESSHHHHHH HHHTTSSSEE EEETHHHHHH 
201 AREKGVQNVH TRLNFVRHRD PGALVTYSGA AVLKSSQNXD EAKKFVAFLA 
HHHH GGG EEEE TTT GGG EEEEEE EEETT SSHH HHHHHHHHHH 
251 GKEGQRALTA VRAEYPLNPH VVSTFNLEPI AXLEAPQVSA TTVSEKEHAT 




(B) Based on an SIB BLAST network service search (S. F. Altschul, et al. Nucleic Acids Res. 
25, 3389 (1997); exception, Halobacterium sp. G229S). Fe ligands (1-19, E57, Y195, Y196) in 





































*Bacteria  with homolog of E. co/i FecA t  Sequences available only up to residues 196-218 
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Summary Information for the Structure of Hf-FBP from Protein Data Bank 
(PDB code 107T) 
Compound: Mol Id: 1; Molecule: Iron Binding Protein; Chain: A, B, C, D, 
E, F, G, H, I; Engineered: Yes 
Exp. Method. X-ray Diffraction 
Classification: Ferric-Binding Protein 
Source. Neisseria gonorrhoeae 
Resolution [A]: 1.65 R- Value: 0.164 
Space Group. P 32 
Unit Cell.- 	dim [A]: 	a148.13 	b148.13 c115.84 
angles ['T alpha 90.00 beta 90.00 gamma 120.00 
Polymer Chains. A, B, C, D, E, F, G, H, I Residues. 2781 
Atoms: 23605 
HETgroups. 	ID Retrieve All 
Name Formula PDBIDs 
Containing 
HF3 SMALLEST HF-OXO- H7015Hf3P HF3 
PHOSPHATE CLUSTER HF3 
HF5 HF OXO CLUSTER HF5 5(H 1202 Hf 5 ) HF5 
PHFHF-OXO-PHOSPHATE 3(H 1 1 O23Hf5P), PHF 
CLUSTER PHF 
Named Sites: HF1, HF2, HF3, HF4, HF5, HF6, HF7, HF8, HF9 
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